PI Metabolism (Homo sapiens)

From WikiPathways

Revision as of 11:38, 1 November 2018 by ReactomeTeam (Talk | contribs)
Jump to: navigation, search
9-11, 15, 38...88, 13178, 101, 1581, 33, 68, 74, 107...63, 111, 123, 1277014, 40, 45, 57, 91...48, 139, 149198, 61, 83, 106, 111...4010685, 1545948, 139, 1495, 734, 75, 9223, 124, 131, 13363, 96, 123, 127, 147311306, 18, 21, 24, 29...10942, 55, 94, 11883, 111, 15561, 83, 111, 112, 155123, 14714, 102, 108, 119, 1636, 18, 21213035, 105, 14254, 6913020, 32, 47, 58, 72...158123, 1471451451221298, 83, 106, 111, 155...23, 111, 124, 131, 13323, 111, 124, 131, 13310981, 87, 125109, 12217, 40, 45, 57, 9162, 70, 8734, 89, 12552, 126, 161123, 1471916, 115, 121144403, 39, 103, 15353, 1103126, 9948, 139, 14937, 95, 986, 8, 56, 61, 64...262, 70, 81, 87, 8936, 66, 68, 74, 107...50, 73, 17263, 111, 123, 12713250, 73, 17225, 51, 8614344, 82, 140, 14626, 99127, 15226, 99, 100, 165, 168...3, 39, 103, 134, 15327, 131, 133, 16413014345, 84, 91, 148, 151977, 22, 28-30, 46...6, 18, 21, 2419316, 8, 56, 64, 111...78, 101, 15825, 8926, 99, 100, 165, 168...early endosome lumenlate endosome lumencytoplasmic vesicle membraneendoplasmic reticulum lumennucleoplasmcytosolGolgi lumenPI4PPI4K2B PI(3,4)P2 PiMTMR4 PIK3C2G ADPMTMR6:MTMR9PIK3CA PI4KA/2BPiPI(3,4)P2PiADPPIP5K1B PIP4K2B ATPPIP5K1A-CH2OH2OPI4PPI4PTNFAIP8L2 PI(4,5)P2,PI(3,4)P2,PI(3,4,5)P3PIK3C2A/3Mg2+ PiMTMR4 Mg2+ SYNJ1 VAC14 ARF1 PI(3,4,5)P3 PLEKHA6 PLEKHA8 PIK3R1 PIK3C2A/3ATPPI(3,4,5)P3 MTMR7 MTMR7 ENPP6PTPN13:PLEKHA1,2ATPSYNJ2 PIP5K1A/BOCRL TCR signalingSYNJs,OCRLMTMR8:MTMR9H2OPIP4K2 dimersPIK3C2A PI3P PiINPP5K PI5PMTMR2 ATPADPPLEKHA5 GTP PIK3R1 PI4KA PIK3C2A MTMR2 TNFAIP8 PiINPP5J INPP4A/BSACM1LATPADPH2ORAB14 SBF2 Ca2+ SYNJ2 PiPIK3R5 PIP5K1B MTMR9 LCFA(-)PIK3C3 INPP4A ATPPIK3R4 ATPMTMR8H2OPIK3R6 PI(4,5)P2PIADPTMEM55BATPPIK3R2 PiPIK3CD MTMR14 PIKFYVE PIK3C2A H2OPiPIK3C3 MTM1,MTMR2,MTMR4,MTMR7ARF1PClysophosphatidylcholineMTM1 MTMR8 PIK3C(1)PTPN13 ATPADPINPPL1 MTMR9PITPNB BMXMTMR9 MTM1 Mg2+ MTMR9 INPP4A PIP4K2C PI(4,5)P2MTMR10 p-Y281,292-RUFY1 PI(3,5)P2ChoRAB4A ADPPC:PITPNBPI FIG4 Regulation of TP53Activity throughAcetylationPIP5K1C SACM1LPLEKHA4,(5,6):PI3PPC PI(3,5)P2PI5P TNFAIP8L3 PI5P, PI3P,PI(3,5)P2MTMR6 OCRL Mg2+ MTMR9 PI4K2A/2BPIK3C2A PIK3C2G TPTE PIK3CA MTM1 PI(3,4)P2 ADPINPP4B ADPPIK3C2A/GPIK3C2A:Ca2+/Mg2+PIP4K2B PIKFYVE:VAC14:FIG4PiH2OADPPI:PITPNBPiG3PINPP5(2)MTMR4 TNFAIP8L1 PiPIMTMR8 MTMR6 PI4KA/2A/2BPLEKHA5 ADPH2OMTMR2:MTMR12PIP5K1C ADPADPGTP ARF1 RAB14 PIK3R3 PiARF1/3:GTP:PI4KBMg2+ MTMR3 PiPI:PITPNBSYNJ1 PCMTMR12 SYNJ2 PIK3R3 PC PIK3(2)INPP5FATPCa2+ Mn2+ H2OPI5PPIK3CD OCRL/INPP5Ep-Y281,292-RUFY1:PI3PPI4PPTPN13 MTMR6PIP5K1A-CATPPI3PPIMTMR1 SBF1 PI4K2A PIP5K1A PLEKHA4,(5,6)GDE1MTMR12PI4KA PI3Pp-Y281,292-RUFY1 ADPPLEKHA1 PIK3C2A PI3P PI3PPIP5K1C Ca2+ RAB14:GTPSYNJ2 PIK3R6 PIK3C2B PIKFYVE:VAC14:FIG4PIP5K1B PLEKHA4 MTMR2 GDPD1PIKFYVE:VAC14:FIG4PI(4,5)P2PITPNB PI4K2A/2BCa2+ MTMR2:MTMR10PI3P Ca2+ PiARF1/3:GTPINPP5D PIPIP3 activates AKTsignalingPIP5K1B VAC14 TPTE2 INPP4B H2OPNPLA7PTENGTP SACM1LARF3 MTMR6 ATPPiPIP4K2A p-Y281,292-RUFY1GTP MTM1,MTMR2,MTMR4PIINPP5E PIK3C3 ARF1 ADPMTMR10InsH2OPI PIK3R4 PLEKHA3 PLEKHA4 p-Y281,292-RUFY1:p-Y281,292-RUFY1:RAB4A:GTP:RAB5:GTP:RAB14:GTPH2OPI(3,5)P2GroPInsPLEKHA2 PI3PPI4P PIP5K1A/BPI4K2B ADPPLEKHA1 PLEKHA3 ARF1:PLEKHA3,8:PI4PPIP4K2A ADPSBF1MAGPLEKHA8 H2OPiH2OPI4K2A PI3PPIP4K2B SYNJ1 PI(3,4)P2ARF3 ADPPIP5K1A PiMTM1 MTMR12 PIKFYVE MTM1PIP4K2/5K1PI(3,4,5)P3H2ORAB5A PI(4,5)P2,PI(3,4,5)P3ADPp-Y281,292-RUFY1ATPCa2+ ATPPIK3CB PiPI4KBPLEKHA3,8PIP4K2 dimersTMEM55BMTMR7PIP4K2A H2OMTM1:MTMR12PiMTMR6:MTMR9,MTMR8:MTMR9MTMR2 PIP5K1A PI(3,5)P2ChoPMTMR2:SBF2 TetramerGTP GTP ATPSYNJ/INPP5(1)PI4K2B PLEKHA6 PI(4,5)P2 RAB5A Mg2+ MTM1,MTMR2,MTMR4,MTMR7TPTE2-like proteinsPIK3C2A/3PI3PPITPNB INPP5(1) H2OVAC14 PI(3,5)P2PIP5K1A PIK3CG MTMR2 PIGDPD3PI5PMTM1 PITPNB SYNJ1 FIG4 PIK3R2 MTM1,MTMR1,MTMR3,MTMR6,MTMR14,SYNJ1,SYNJ2RAB4A FIG4 MTMR2:SBF1MTMR2 ADPSYNJs,OCRLMTMR2 PIP4K2C ATPPI(4,5)P2 SBF2 homodimerPIK3R4 H2OTNFAIP8 proteinsPI4KB PNPLA6ATPPTPN13:PLEKHA1,2:PIP2RUFY1PI5PATPMn2+ PIKFYVE RAB4A:GTPPIP5K1B PIK3CG PI5PRAB5A:GTPPI4K2A PI(3,4,5)P3 Mn2+ PI(4,5)P2,PI(3,4,5)P3PIK3R5 H2OPIP5K1A PI3PPIK3C2A H2OMTMR2 homodimerPLEKHA2 MTMR7 MTMR7:MTMR9ADPPiPI(3,5)P2 PC:PITPNBMTMR2 PI(3,4)P2GPChoPIK3CB OCRL PI4K2B Mn2+ GDPD5EPH-Ephrin signalingATPMTMR2H2OSBF2 INPP4A/BPI(4,5)P2 ADPLysoPtdCho1065912, 13, 79, 80, 116...15813010813048, 139, 14967, 12012210812165, 150, 16215895132109130


Description

Phosphatidylinositol (PI), a membrane phospholipid, can be reversibly phosphorylated at the 3, 4, and 5 positions of the inositol ring to generate seven phosphoinositides: phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate (PI4P), phosphatidylinositol 5-phosphate (PI5P), phosphatidylinositol 3,4-bisphosphate PI(3,4)P2, phosphatidylinositol 4,5-bisphosphate PI(4,5)P2, phosphatidylinositol 3,5-bisphosphate PI(3,5)P2, and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). These seven phosphoinositides, which are heterogeneously distributed within cells, can serve as signature components of different intracellular compartment membranes and so help to mediate specificity of membrane interactions. Phosphoinositide levels are tightly regulated spatially and temporally by the action of various kinases and phosphatases whilst PI(4,5)P2 is also a substrate for phospholipase C. The differential localisation of each of these enzymes on specific compartment membranes ensures maintenance of the heterogeneous distribution of phosphoinositides despite the continuous membrane flow from one compartment to another.

PI is primarily synthesised in the endoplasmic reticulum from where the phospholipid is exported to other compartments via membrane traffic or via cytosolic phospholipid transfer proteins. Phosphorylation of PI to PI4P primarily occurs in the Golgi, where PI4P plays an important role in the biogenesis of transport vesicles such as the secretory vesicle involved in its transport to the plasma membrane. At this place, PI4P has a major function acting as a precursor of PI(4,5)P2, which is located predominantly at this membrane. PI(4,5)P2 binds and regulates a wide range of proteins that function on the cell surface and serves as a precursor for second messengers. Additionally, it helps define this membrane as a target for secretory vesicles, functions as a coreceptor in endocytic processes, and functions as a cofactor for actin nucleation.

At the plasma membrane, PI(4,5)P2 is further phosphorylated to PI(3,4,5)P3, another phosphoinositide with important signalling functions including stimulating cell survival and proliferation. The inositol 3-phosphatase, phosphatase and tensin homolog (PTEN) regenerates PI(4,5)P2, while the 5-phosphatases convert PI(3,4,5)P3 into the phosphoinositide, PI(3,4)P2, propagating the signal initiated by PI(3,4,5)P3. PI(3,4)P2 is further dephosphorylated in the endocytic pathway by inositol 4-phosphatases to PI3P, the signature phosphoinositide of the early endosomal compartment and a ligand for numerous endosomal proteins. However, the bulk of PI3P is generated directly in the endosomes by phosphorylation of PI. The subsequent endosomal phosphorylation of PI3P to PI(3,5)P2 is believed to generate docking sites for recruitment of cytosolic factors responsible for the control of outgoing traffic from the endosomes. The main localisation and function of the low abundance phosphoinositide PI5P, that can be generated by several pathways, remains to be determined (Krauss & Haucke 2007, Leventis & Grinstein 2010, Roth 2004, Gees et al. 2010, De Matteis & Godi 2004, van Meer et al. 2008, Vicinanza et al. 2008, Lemmon 2008, Kutaleladze 2010, Robinson & Dixon 2006, Blero et al. 2007, Liu & Bankaitis 2010, McCrea & De Camilli 2009, Vicinanza et al. 2008, Di Paolo & De Camilli, 2006). View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 1483255
Reactome-version 
Reactome version: 66
Reactome Author 
Reactome Author: Williams, MG

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Rudd CE, Schneider H.; ''Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.''; PubMed Europe PMC Scholia
  2. Kabuyama Y, Nakatsu N, Homma Y, Fukui Y.; ''Purification and characterization of the phosphatidylinositol-3,4,5-trisphosphate phosphatase in bovine thymus.''; PubMed Europe PMC Scholia
  3. Suzuki K, Hirano H, Okutomi K, Suzuki M, Kuga Y, Fujiwara T, Kanemoto N, Isono K, Horie M.; ''Identification and characterization of a novel human phosphatidylinositol 4-kinase.''; PubMed Europe PMC Scholia
  4. Rameh LE, Tolias KF, Duckworth BC, Cantley LC.; ''A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.''; PubMed Europe PMC Scholia
  5. Ono F, Nakagawa T, Saito S, Owada Y, Sakagami H, Goto K, Suzuki M, Matsuno S, Kondo H.; ''A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration.''; PubMed Europe PMC Scholia
  6. Norris FA, Auethavekiat V, Majerus PW.; ''The isolation and characterization of cDNA encoding human and rat brain inositol polyphosphate 4-phosphatase.''; PubMed Europe PMC Scholia
  7. Norris FA, Atkins RC, Majerus PW.; ''The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family.''; PubMed Europe PMC Scholia
  8. Clarke JH, Irvine RF.; ''Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization.''; PubMed Europe PMC Scholia
  9. Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, Lamon C, Hutter P, Antonarakis SE.; ''The TPTE gene family: cellular expression, subcellular localization and alternative splicing.''; PubMed Europe PMC Scholia
  10. Carvou N, Holic R, Li M, Futter C, Skippen A, Cockcroft S.; ''Phosphatidylinositol- and phosphatidylcholine-transfer activity of PITPbeta is essential for COPI-mediated retrograde transport from the Golgi to the endoplasmic reticulum.''; PubMed Europe PMC Scholia
  11. Dey BR, Furlanetto RW, Nissley SP.; ''Cloning of human p55 gamma, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor.''; PubMed Europe PMC Scholia
  12. Clarke JH, Giudici ML, Burke JE, Williams RL, Maloney DJ, Marugan J, Irvine RF.; ''The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding site.''; PubMed Europe PMC Scholia
  13. Luo J, Su F, Chen D, Shiloh A, Gu W.; ''Deacetylation of p53 modulates its effect on cell growth and apoptosis.''; PubMed Europe PMC Scholia
  14. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ.; ''Characterization of the human patatin-like phospholipase family.''; PubMed Europe PMC Scholia
  15. Tsujita K, Itoh T, Ijuin T, Yamamoto A, Shisheva A, Laporte J, Takenawa T.; ''Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction.''; PubMed Europe PMC Scholia
  16. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P, Hawkins PT.; ''The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.''; PubMed Europe PMC Scholia
  17. Cao C, Laporte J, Backer JM, Wandinger-Ness A, Stein MP.; ''Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes.''; PubMed Europe PMC Scholia
  18. Ikonomov OC, Sbrissa D, Shisheva A.; ''Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion.''; PubMed Europe PMC Scholia
  19. Gurung R, Tan A, Ooms LM, McGrath MJ, Huysmans RD, Munday AD, Prescott M, Whisstock JC, Mitchell CA.; ''Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization. The inositol 5-phosphatase skip localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation.''; PubMed Europe PMC Scholia
  20. Tolias KF, Rameh LE, Ishihara H, Shibasaki Y, Chen J, Prestwich GD, Cantley LC, Carpenter CL.; ''Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate.''; PubMed Europe PMC Scholia
  21. Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, Geromanos S, Kavanaugh WM, Tempst P, Clarkson B.; ''A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.''; PubMed Europe PMC Scholia
  22. Hein MY, Hubner NC, Poser I, Cox J, Nagaraj N, Toyoda Y, Gak IA, Weisswange I, Mansfeld J, Buchholz F, Hyman AA, Mann M.; ''A human interactome in three quantitative dimensions organized by stoichiometries and abundances.''; PubMed Europe PMC Scholia
  23. Minogue S, Anderson JS, Waugh MG, dos Santos M, Corless S, Cramer R, Hsuan JJ.; ''Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family.''; PubMed Europe PMC Scholia
  24. Ijuin T, Mochizuki Y, Fukami K, Funaki M, Asano T, Takenawa T.; ''Identification and characterization of a novel inositol polyphosphate 5-phosphatase.''; PubMed Europe PMC Scholia
  25. Haffner C, Takei K, Chen H, Ringstad N, Hudson A, Butler MH, Salcini AE, Di Fiore PP, De Camilli P.; ''Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15.''; PubMed Europe PMC Scholia
  26. Nandurkar HH, Layton M, Laporte J, Selan C, Corcoran L, Caldwell KK, Mochizuki Y, Majerus PW, Mitchell CA.; ''Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP.''; PubMed Europe PMC Scholia
  27. Clarke JH, Wang M, Irvine RF.; ''Localization, regulation and function of type II phosphatidylinositol 5-phosphate 4-kinases.''; PubMed Europe PMC Scholia
  28. Gallazzini M, Ferraris JD, Kunin M, Morris RG, Burg MB.; ''Neuropathy target esterase catalyzes osmoprotective renal synthesis of glycerophosphocholine in response to high NaCl.''; PubMed Europe PMC Scholia
  29. Kong AM, Speed CJ, O'Malley CJ, Layton MJ, Meehan T, Loveland KL, Cheema S, Ooms LM, Mitchell CA.; ''Cloning and characterization of a 72-kDa inositol-polyphosphate 5-phosphatase localized to the Golgi network.''; PubMed Europe PMC Scholia
  30. Wei YJ, Sun HQ, Yamamoto M, Wlodarski P, Kunii K, Martinez M, Barylko B, Albanesi JP, Yin HL.; ''Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP.''; PubMed Europe PMC Scholia
  31. Zaccheo O, Dinsdale D, Meacock PA, Glynn P.; ''Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells.''; PubMed Europe PMC Scholia
  32. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA.; ''Function and dysfunction of the PI system in membrane trafficking.''; PubMed Europe PMC Scholia
  33. Kim SA, Vacratsis PO, Firestein R, Cleary ML, Dixon JE.; ''Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase.''; PubMed Europe PMC Scholia
  34. McEwen RK, Dove SK, Cooke FT, Painter GF, Holmes AB, Shisheva A, Ohya Y, Parker PJ, Michell RH.; ''Complementation analysis in PtdInsP kinase-deficient yeast mutants demonstrates that Schizosaccharomyces pombe and murine Fab1p homologues are phosphatidylinositol 3-phosphate 5-kinases.''; PubMed Europe PMC Scholia
  35. Rutherford AC, Traer C, Wassmer T, Pattni K, Bujny MV, Carlton JG, Stenmark H, Cullen PJ.; ''The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport.''; PubMed Europe PMC Scholia
  36. Oude Weernink PA, López de Jesús M, Schmidt M.; ''Phospholipase D signaling: orchestration by PIP2 and small GTPases.''; PubMed Europe PMC Scholia
  37. Krauss M, Haucke V.; ''Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling.''; PubMed Europe PMC Scholia
  38. Li Y, Dinsdale D, Glynn P.; ''Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in Mammalian cells.''; PubMed Europe PMC Scholia
  39. Dunant NM, Wisniewski D, Strife A, Clarkson B, Resh MD.; ''The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.''; PubMed Europe PMC Scholia
  40. Tilley SJ, Skippen A, Murray-Rust J, Swigart PM, Stewart A, Morgan CP, Cockcroft S, McDonald NQ.; ''Structure-function analysis of human [corrected] phosphatidylinositol transfer protein alpha bound to phosphatidylinositol.''; PubMed Europe PMC Scholia
  41. Lorenzo O, Urbé S, Clague MJ.; ''Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3.''; PubMed Europe PMC Scholia
  42. Cui J, Hao C, Zhang W, Shao J, Zhang N, Zhang G, Liu S.; ''Identical expression profiling of human and murine TIPE3 protein reveals links to its functions.''; PubMed Europe PMC Scholia
  43. Zou J, Chang SC, Marjanovic J, Majerus PW.; ''MTMR9 increases MTMR6 enzyme activity, stability, and role in apoptosis.''; PubMed Europe PMC Scholia
  44. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP.; ''Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.''; PubMed Europe PMC Scholia
  45. Domin J, Gaidarov I, Smith ME, Keen JH, Waterfield MD.; ''The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrated in the trans-Golgi network and present in clathrin-coated vesicles.''; PubMed Europe PMC Scholia
  46. Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, Daniele T, Marra P, Lucocq JM, De Matteis MA.; ''FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P.''; PubMed Europe PMC Scholia
  47. Arcaro A, Zvelebil MJ, Wallasch C, Ullrich A, Waterfield MD, Domin J.; ''Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.''; PubMed Europe PMC Scholia
  48. Di Paolo G, De Camilli P.; ''Phosphoinositides in cell regulation and membrane dynamics.''; PubMed Europe PMC Scholia
  49. Shadan S, Holic R, Carvou N, Ee P, Li M, Murray-Rust J, Cockcroft S.; ''Dynamics of lipid transfer by phosphatidylinositol transfer proteins in cells.''; PubMed Europe PMC Scholia
  50. Arvanitis D, Davy A.; ''Eph/ephrin signaling: networks.''; PubMed Europe PMC Scholia
  51. Sbrissa D, Ikonomov OC, Shisheva A.; ''PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin.''; PubMed Europe PMC Scholia
  52. Chen Y, Fu AK, Ip NY.; ''Eph receptors at synapses: implications in neurodegenerative diseases.''; PubMed Europe PMC Scholia
  53. Panaretou C, Domin J, Cockcroft S, Waterfield MD.; ''Characterization of p150, an adaptor protein for the human phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by phosphatidylinositol transfer protein to the p150.Ptdins 3-kinase complex.''; PubMed Europe PMC Scholia
  54. Zou J, Zhang C, Marjanovic J, Kisseleva MV, Majerus PW, Wilson MP.; ''Myotubularin-related protein (MTMR) 9 determines the enzymatic activity, substrate specificity, and role in autophagy of MTMR8.''; PubMed Europe PMC Scholia
  55. Zhang X, Jefferson AB, Auethavekiat V, Majerus PW.; ''The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.''; PubMed Europe PMC Scholia
  56. Gallazzini M, Ferraris JD, Burg MB.; ''GDPD5 is a glycerophosphocholine phosphodiesterase that osmotically regulates the osmoprotective organic osmolyte GPC.''; PubMed Europe PMC Scholia
  57. Larance M, Ramm G, Stöckli J, van Dam EM, Winata S, Wasinger V, Simpson F, Graham M, Junutula JR, Guilhaus M, James DE.; ''Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking.''; PubMed Europe PMC Scholia
  58. Liu Y, Bankaitis VA.; ''Phosphoinositide phosphatases in cell biology and disease.''; PubMed Europe PMC Scholia
  59. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA.; ''Phosphoinositides as regulators of membrane trafficking in health and disease.''; PubMed Europe PMC Scholia
  60. Sbrissa D, Ikonomov OC, Fenner H, Shisheva A.; ''ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality.''; PubMed Europe PMC Scholia
  61. Szentpetery Z, Várnai P, Balla T.; ''Acute manipulation of Golgi phosphoinositides to assess their importance in cellular trafficking and signaling.''; PubMed Europe PMC Scholia
  62. Krauss M, Kinuta M, Wenk MR, De Camilli P, Takei K, Haucke V.; ''ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma.''; PubMed Europe PMC Scholia
  63. Laporte J, Blondeau F, Gansmuller A, Lutz Y, Vonesch JL, Mandel JL.; ''The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles.''; PubMed Europe PMC Scholia
  64. Zheng B, Chen D, Farquhar MG.; ''MIR16, a putative membrane glycerophosphodiester phosphodiesterase, interacts with RGS16.''; PubMed Europe PMC Scholia
  65. Di Paolo G, Pellegrini L, Letinic K, Cestra G, Zoncu R, Voronov S, Chang S, Guo J, Wenk MR, De Camilli P.; ''Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin.''; PubMed Europe PMC Scholia
  66. Bultsma Y, Keune WJ, Divecha N.; ''PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha.''; PubMed Europe PMC Scholia
  67. Bielas SL, Silhavy JL, Brancati F, Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS, Abdel-Aleem A, Rosti RO, Kayserili H, Swistun D, Scott LC, Bertini E, Boltshauser E, Fazzi E, Travaglini L, Field SJ, Gayral S, Jacoby M, Schurmans S, Dallapiccola B, Majerus PW, Valente EM, Gleeson JG.; ''Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.''; PubMed Europe PMC Scholia
  68. Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P, Stephens L.; ''p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma.''; PubMed Europe PMC Scholia
  69. Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH, Zvelebil MJ, Higashi K, Volinia S, Downward J, Waterfield MD.; ''P110delta, a novel phosphoinositide 3-kinase in leukocytes.''; PubMed Europe PMC Scholia
  70. Yoder MD, Thomas LM, Tremblay JM, Oliver RL, Yarbrough LR, Helmkamp GM.; ''Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine.''; PubMed Europe PMC Scholia
  71. Pesesse X, Dewaste V, De Smedt F, Laffargue M, Giuriato S, Moreau C, Payrastre B, Erneux C.; ''The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.''; PubMed Europe PMC Scholia
  72. van Leeuwen JE, Samelson LE.; ''T cell antigen-receptor signal transduction.''; PubMed Europe PMC Scholia
  73. Volinia S, Dhand R, Vanhaesebroeck B, MacDougall LK, Stein R, Zvelebil MJ, Domin J, Panaretou C, Waterfield MD.; ''A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system.''; PubMed Europe PMC Scholia
  74. Halstead JR, van Rheenen J, Snel MH, Meeuws S, Mohammed S, D'Santos CS, Heck AJ, Jalink K, Divecha N.; ''A role for PtdIns(4,5)P2 and PIP5Kalpha in regulating stress-induced apoptosis.''; PubMed Europe PMC Scholia
  75. Kimber WA, Deak M, Prescott AR, Alessi DR.; ''Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.''; PubMed Europe PMC Scholia
  76. Burrows AE, Smogorzewska A, Elledge SJ.; ''Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.''; PubMed Europe PMC Scholia
  77. Walker SM, Downes CP, Leslie NR.; ''TPIP: a novel phosphoinositide 3-phosphatase.''; PubMed Europe PMC Scholia
  78. Maehama T, Dixon JE.; ''The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.''; PubMed Europe PMC Scholia
  79. Sbrissa D, Ikonomov OC, Shisheva A.; ''Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization.''; PubMed Europe PMC Scholia
  80. Roth MG.; ''Phosphoinositides in constitutive membrane traffic.''; PubMed Europe PMC Scholia
  81. Zou J, Marjanovic J, Kisseleva MV, Wilson M, Majerus PW.; ''Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis.''; PubMed Europe PMC Scholia
  82. Wullschleger S, Wasserman DH, Gray A, Sakamoto K, Alessi DR.; ''Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis.''; PubMed Europe PMC Scholia
  83. Schouten A, Agianian B, Westerman J, Kroon J, Wirtz KW, Gros P.; ''Structure of apo-phosphatidylinositol transfer protein alpha provides insight into membrane association.''; PubMed Europe PMC Scholia
  84. Ikonomov OC, Sbrissa D, Shisheva A.; ''Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve.''; PubMed Europe PMC Scholia
  85. Gees M, Colsoul B, Nilius B.; ''The role of transient receptor potential cation channels in Ca2+ signaling.''; PubMed Europe PMC Scholia
  86. Kutateladze TG.; ''Translation of the phosphoinositide code by PI effectors.''; PubMed Europe PMC Scholia
  87. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nürnberg B.; ''Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.''; PubMed Europe PMC Scholia
  88. Ohshima N, Kudo T, Yamashita Y, Mariggiò S, Araki M, Honda A, Nagano T, Isaji C, Kato N, Corda D, Izumi T, Yanaka N.; ''New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity.''; PubMed Europe PMC Scholia
  89. Balla A, Tuymetova G, Barshishat M, Geiszt M, Balla T.; ''Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments.''; PubMed Europe PMC Scholia
  90. Watt SA, Kimber WA, Fleming IN, Leslie NR, Downes CP, Lucocq JM.; ''Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopy.''; PubMed Europe PMC Scholia
  91. Jones DR, Bultsma Y, Keune WJ, Halstead JR, Elouarrat D, Mohammed S, Heck AJ, D'Santos CS, Divecha N.; ''Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta.''; PubMed Europe PMC Scholia
  92. Rudd CE.; ''Adaptors and molecular scaffolds in immune cell signaling.''; PubMed Europe PMC Scholia
  93. Zhao R, Qi Y, Chen J, Zhao ZJ.; ''FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate.''; PubMed Europe PMC Scholia
  94. Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR.; ''Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities.''; PubMed Europe PMC Scholia
  95. Gupta VA, Hnia K, Smith LL, Gundry SR, McIntire JE, Shimazu J, Bass JR, Talbot EA, Amoasii L, Goldman NE, Laporte J, Beggs AH.; ''Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.''; PubMed Europe PMC Scholia
  96. Sakagami H, Aoki J, Natori Y, Nishikawa K, Kakehi Y, Natori Y, Arai H.; ''Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.''; PubMed Europe PMC Scholia
  97. Mochizuki Y, Majerus PW.; ''Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.''; PubMed Europe PMC Scholia
  98. Kienesberger PC, Lass A, Preiss-Landl K, Wolinski H, Kohlwein SD, Zimmermann R, Zechner R.; ''Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase.''; PubMed Europe PMC Scholia
  99. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK.; ''The lipid phosphatase activity of PTEN is critical for its tumor supressor function.''; PubMed Europe PMC Scholia
  100. Misawa H, Ohtsubo M, Copeland NG, Gilbert DJ, Jenkins NA, Yoshimura A.; ''Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain.''; PubMed Europe PMC Scholia
  101. Zhang X, Loijens JC, Boronenkov IV, Parker GJ, Norris FA, Chen J, Thum O, Prestwich GD, Majerus PW, Anderson RA.; ''Phosphatidylinositol-4-phosphate 5-kinase isozymes catalyze the synthesis of 3-phosphate-containing phosphatidylinositol signaling molecules.''; PubMed Europe PMC Scholia
  102. Sbrissa D, Ikonomov OC, Fu Z, Ijuin T, Gruenberg J, Takenawa T, Shisheva A.; ''Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex.''; PubMed Europe PMC Scholia
  103. Ivetac I, Munday AD, Kisseleva MV, Zhang XM, Luff S, Tiganis T, Whisstock JC, Rowe T, Majerus PW, Mitchell CA.; ''The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.''; PubMed Europe PMC Scholia
  104. Ciruela A, Hinchliffe KA, Divecha N, Irvine RF.; ''Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7.''; PubMed Europe PMC Scholia
  105. Clarke JH, Emson PC, Irvine RF.; ''Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron.''; PubMed Europe PMC Scholia
  106. Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C.; ''MOZ increases p53 acetylation and premature senescence through its complex formation with PML.''; PubMed Europe PMC Scholia
  107. Lorenzo O, Urbé S, Clague MJ.; ''Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.''; PubMed Europe PMC Scholia
  108. Arcaro A, Volinia S, Zvelebil MJ, Stein R, Watton SJ, Layton MJ, Gout I, Ahmadi K, Downward J, Waterfield MD.; ''Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity.''; PubMed Europe PMC Scholia
  109. Berger P, Schaffitzel C, Berger I, Ban N, Suter U.; ''Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module.''; PubMed Europe PMC Scholia
  110. Fayngerts SA, Wu J, Oxley CL, Liu X, Vourekas A, Cathopoulis T, Wang Z, Cui J, Liu S, Sun H, Lemmon MA, Zhang L, Shi Y, Chen YH.; ''TIPE3 is the transfer protein of lipid second messengers that promote cancer.''; PubMed Europe PMC Scholia
  111. Das S, Dixon JE, Cho W.; ''Membrane-binding and activation mechanism of PTEN.''; PubMed Europe PMC Scholia
  112. Blero D, Payrastre B, Schurmans S, Erneux C.; ''Phosphoinositide phosphatases in a network of signalling reactions.''; PubMed Europe PMC Scholia
  113. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W.; ''Ferroptosis as a p53-mediated activity during tumour suppression.''; PubMed Europe PMC Scholia
  114. Kim SA, Taylor GS, Torgersen KM, Dixon JE.; ''Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.''; PubMed Europe PMC Scholia
  115. Haynes LP, Sherwood MW, Dolman NJ, Burgoyne RD.; ''Specificity, promiscuity and localization of ARF protein interactions with NCS-1 and phosphatidylinositol-4 kinase-III beta.''; PubMed Europe PMC Scholia
  116. Walker DM, Urbé S, Dove SK, Tenza D, Raposo G, Clague MJ.; ''Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity.''; PubMed Europe PMC Scholia
  117. Choudhury P, Srivastava S, Li Z, Ko K, Albaqumi M, Narayan K, Coetzee WA, Lemmon MA, Skolnik EY.; ''Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain.''; PubMed Europe PMC Scholia
  118. Guo S, Stolz LE, Lemrow SM, York JD.; ''SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases.''; PubMed Europe PMC Scholia
  119. Schaletzky J, Dove SK, Short B, Lorenzo O, Clague MJ, Barr FA.; ''Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases.''; PubMed Europe PMC Scholia
  120. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH.; ''TIGAR, a p53-inducible regulator of glycolysis and apoptosis.''; PubMed Europe PMC Scholia
  121. Fouraux MA, Deneka M, Ivan V, van der Heijden A, Raymackers J, van Suylekom D, van Venrooij WJ, van der Sluijs P, Pruijn GJ.; ''Rabip4' is an effector of rab5 and rab4 and regulates transport through early endosomes.''; PubMed Europe PMC Scholia
  122. Voigt P, Dorner MB, Schaefer M.; ''Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B.''; PubMed Europe PMC Scholia
  123. Marshall AJ, Krahn AK, Ma K, Duronio V, Hou S.; ''TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor.''; PubMed Europe PMC Scholia
  124. De Matteis MA, Godi A.; ''PI-loting membrane traffic.''; PubMed Europe PMC Scholia
  125. Tosch V, Rohde HM, Tronchère H, Zanoteli E, Monroy N, Kretz C, Dondaine N, Payrastre B, Mandel JL, Laporte J.; ''A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.''; PubMed Europe PMC Scholia
  126. Gehrmann T, Gülkan H, Suer S, Herberg FW, Balla A, Vereb G, Mayr GW, Heilmeyer LM.; ''Functional expression and characterisation of a new human phosphatidylinositol 4-kinase PI4K230.''; PubMed Europe PMC Scholia
  127. Lou Y, Liu S.; ''The TIPE (TNFAIP8) family in inflammation, immunity, and cancer.''; PubMed Europe PMC Scholia
  128. Choudhury R, Noakes CJ, McKenzie E, Kox C, Lowe M.; ''Differential clathrin binding and subcellular localization of OCRL1 splice isoforms.''; PubMed Europe PMC Scholia
  129. Malecz N, McCabe PC, Spaargaren C, Qiu R, Chuang Y, Symons M.; ''Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis.''; PubMed Europe PMC Scholia
  130. Cao C, Backer JM, Laporte J, Bedrick EJ, Wandinger-Ness A.; ''Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking.''; PubMed Europe PMC Scholia
  131. van Meer G, Voelker DR, Feigenson GW.; ''Membrane lipids: where they are and how they behave.''; PubMed Europe PMC Scholia
  132. Tang Y, Luo J, Zhang W, Gu W.; ''Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.''; PubMed Europe PMC Scholia
  133. Caldwell KK, Lips DL, Bansal VS, Majerus PW.; ''Isolation and characterization of two 3-phosphatases that hydrolyze both phosphatidylinositol 3-phosphate and inositol 1,3-bisphosphate.''; PubMed Europe PMC Scholia
  134. Oude Weernink PA, Schmidt M, Jakobs KH.; ''Regulation and cellular roles of phosphoinositide 5-kinases.''; PubMed Europe PMC Scholia
  135. Godi A, Pertile P, Meyers R, Marra P, Di Tullio G, Iurisci C, Luini A, Corda D, De Matteis MA.; ''ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex.''; PubMed Europe PMC Scholia
  136. Wong K, Meyers ddR, Cantley LC.; ''Subcellular locations of phosphatidylinositol 4-kinase isoforms.''; PubMed Europe PMC Scholia
  137. Rohde HM, Cheong FY, Konrad G, Paiha K, Mayinger P, Boehmelt G.; ''The human phosphatidylinositol phosphatase SAC1 interacts with the coatomer I complex.''; PubMed Europe PMC Scholia
  138. Suchy SF, Olivos-Glander IM, Nussabaum RL.; ''Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.''; PubMed Europe PMC Scholia
  139. Lemmon MA.; ''Membrane recognition by phospholipid-binding domains.''; PubMed Europe PMC Scholia
  140. Mani M, Lee SY, Lucast L, Cremona O, Di Paolo G, De Camilli P, Ryan TA.; ''The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.''; PubMed Europe PMC Scholia
  141. Bachmann AS, Duennebier FF, Mocz G.; ''Genomic organization, characterization, and molecular 3D model of GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase.''; PubMed Europe PMC Scholia
  142. Habib T, Hejna JA, Moses RE, Decker SJ.; ''Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein.''; PubMed Europe PMC Scholia
  143. Li W, Ouyang Z, Zhang Q, Wang L, Shen Y, Wu X, Gu Y, Shu Y, Yu B, Wu X, Sun Y, Xu Q.; ''SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2.''; PubMed Europe PMC Scholia
  144. Yang J, Kim O, Wu J, Qiu Y.; ''Interaction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle trafficking.''; PubMed Europe PMC Scholia
  145. Leventis PA, Grinstein S.; ''The distribution and function of phosphatidylserine in cellular membranes.''; PubMed Europe PMC Scholia
  146. Mari M, Monzo P, Kaddai V, Keslair F, Gonzalez T, Le Marchand-Brustel Y, Cormont M.; ''The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes.''; PubMed Europe PMC Scholia
  147. Krag C, Malmberg EK, Salcini AE.; ''PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways.''; PubMed Europe PMC Scholia
  148. Kavanaugh WM, Pot DA, Chin SM, Deuter-Reinhard M, Jefferson AB, Norris FA, Masiarz FR, Cousens LS, Majerus PW, Williams LT.; ''Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.''; PubMed Europe PMC Scholia
  149. Kisseleva MV, Wilson MP, Majerus PW.; ''The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase.''; PubMed Europe PMC Scholia
  150. Tronchère H, Laporte J, Pendaries C, Chaussade C, Liaubet L, Pirola L, Mandel JL, Payrastre B.; ''Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells.''; PubMed Europe PMC Scholia
  151. Rozycka M, Lu YJ, Brown RA, Lau MR, Shipley JM, Fry MJ.; ''cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K-C2gamma, and chromosomal assignment of this gene (PIK3C2G) to 12p12.''; PubMed Europe PMC Scholia
  152. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R, Del Sal G.; ''BRD7 is a candidate tumour suppressor gene required for p53 function.''; PubMed Europe PMC Scholia
  153. Guo X, Ghalayini AJ, Chen H, Anderson RE.; ''Phosphatidylinositol 3-kinase in bovine photoreceptor rod outer segments.''; PubMed Europe PMC Scholia
  154. Hammond GR, Schiavo G, Irvine RF.; ''Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2).''; PubMed Europe PMC Scholia
  155. Vordtriede PB, Doan CN, Tremblay JM, Helmkamp GM, Yoder MD.; ''Structure of PITPbeta in complex with phosphatidylcholine: comparison of structure and lipid transfer to other PITP isoforms.''; PubMed Europe PMC Scholia
  156. Mochizuki Y, Takenawa T.; ''Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles.''; PubMed Europe PMC Scholia
  157. Nakatsu F, Messa M, Nández R, Czapla H, Zou Y, Strittmatter SM, De Camilli P.; ''Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway.''; PubMed Europe PMC Scholia
  158. McCrea HJ, De Camilli P.; ''Mutations in phosphoinositide metabolizing enzymes and human disease.''; PubMed Europe PMC Scholia
  159. Moniz LS, Vanhaesebroeck B.; ''A new TIPE of phosphoinositide regulator in cancer.''; PubMed Europe PMC Scholia
  160. Berger P, Berger I, Schaffitzel C, Tersar K, Volkmer B, Suter U.; ''Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2.''; PubMed Europe PMC Scholia
  161. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W.; ''Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.''; PubMed Europe PMC Scholia
  162. Zheng B, Berrie CP, Corda D, Farquhar MG.; ''GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors.''; PubMed Europe PMC Scholia
  163. Meier TI, Cook JA, Thomas JE, Radding JA, Horn C, Lingaraj T, Smith MC.; ''Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.''; PubMed Europe PMC Scholia
  164. Cabezas A, Pattni K, Stenmark H.; ''Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1.''; PubMed Europe PMC Scholia
  165. Sbrissa D, Ikonomov OC, Deeb R, Shisheva A.; ''Phosphatidylinositol 5-phosphate biosynthesis is linked to PIKfyve and is involved in osmotic response pathway in mammalian cells.''; PubMed Europe PMC Scholia
  166. Robinson FL, Dixon JE.; ''Myotubularin phosphatases: policing 3-phosphoinositides.''; PubMed Europe PMC Scholia
  167. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, McMahon SB.; ''Acetylation of the p53 DNA-binding domain regulates apoptosis induction.''; PubMed Europe PMC Scholia
  168. Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L, Arioka M, Martin TF, De Camilli P.; ''PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse.''; PubMed Europe PMC Scholia
  169. Johenning FW, Wenk MR, Uhlén P, Degray B, Lee E, De Camilli P, Ehrlich BE.; ''InsP3-mediated intracellular calcium signalling is altered by expression of synaptojanin-1.''; PubMed Europe PMC Scholia
  170. Yamada K, Nomura N, Yamano A, Yamada Y, Wakamatsu N.; ''Identification and characterization of splicing variants of PLEKHA5 (Plekha5) during brain development.''; PubMed Europe PMC Scholia
  171. Kitagishi Y, Matsuda S.; ''RUFY, Rab and Rap Family Proteins Involved in a Regulation of Cell Polarity and Membrane Trafficking.''; PubMed Europe PMC Scholia
  172. Drayer AL, Pesesse X, De Smedt F, Woscholski R, Parker P, Erneux C.; ''Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114955view16:48, 25 January 2021ReactomeTeamReactome version 75
113399view11:47, 2 November 2020ReactomeTeamReactome version 74
112603view15:58, 9 October 2020ReactomeTeamReactome version 73
101519view11:38, 1 November 2018ReactomeTeamreactome version 66
101055view21:20, 31 October 2018ReactomeTeamreactome version 65
100586view19:54, 31 October 2018ReactomeTeamreactome version 64
100135view16:39, 31 October 2018ReactomeTeamreactome version 63
99685view15:08, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93921view13:45, 16 August 2017ReactomeTeamreactome version 61
93500view11:25, 9 August 2017ReactomeTeamreactome version 61
88092view09:25, 26 July 2016RyanmillerOntology Term : 'lipid metabolic pathway' added !
88091view09:23, 26 July 2016RyanmillerOntology Term : 'classic metabolic pathway' added !
86595view09:21, 11 July 2016ReactomeTeamreactome version 56
83160view10:14, 18 November 2015ReactomeTeamVersion54
81516view13:03, 21 August 2015ReactomeTeamVersion53
76987view08:27, 17 July 2014ReactomeTeamFixed remaining interactions
76692view12:05, 16 July 2014ReactomeTeamFixed remaining interactions
76018view10:08, 11 June 2014ReactomeTeamRe-fixing comment source
75727view11:20, 10 June 2014ReactomeTeamReactome 48 Update
75077view14:02, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74724view08:48, 30 April 2014ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ADPMetaboliteCHEBI:16761 (ChEBI)
ARF1 ProteinP84077 (Uniprot-TrEMBL)
ARF1/3:GTP:PI4KBComplexR-HSA-1806287 (Reactome)
ARF1/3:GTPComplexR-HSA-1806258 (Reactome)
ARF1:PLEKHA3,8:PI4PComplexR-HSA-8870493 (Reactome)
ARF1ProteinP84077 (Uniprot-TrEMBL)
ARF3 ProteinP61204 (Uniprot-TrEMBL)
ATPMetaboliteCHEBI:15422 (ChEBI)
BMXProteinP51813 (Uniprot-TrEMBL)
Ca2+ MetaboliteCHEBI:29108 (ChEBI)
ChoMetaboliteCHEBI:15354 (ChEBI)
ChoPMetaboliteCHEBI:18132 (ChEBI)
ENPP6ProteinQ6UWR7 (Uniprot-TrEMBL)
EPH-Ephrin signalingPathwayR-HSA-2682334 (Reactome) During the development process cell migration and adhesion are the main forces involved in morphing the cells into critical anatomical structures. The ability of a cell to migrate to its correct destination depends heavily on signaling at the cell membrane. Erythropoietin producing hepatocellular carcinoma (EPH) receptors and their ligands, the ephrins (EPH receptors interacting proteins, EFNs), orchestrates the precise control necessary to guide a cell to its destination. They are expressed in all tissues of a developing embryo and are involved in multiple developmental processes such as axon guidance, cardiovascular and skeletal development and tissue patterning. In addition, EPH receptors and EFNs are expressed in developing and mature synapses in the nervous system, where they may have a role in regulating synaptic plasticity and long-term potentiation. Activation of EPHB receptors in neurons induces the rapid formation and enlargement of dendritic spines, as well as rapid synapse maturation (Dalva et al. 2007). On the other hand, EPHA4 activation leads to dendritic spine elimination (Murai et al. 2003, Fu et al. 2007).
EPH receptors are the largest known family of receptor tyrosine kinases (RTKs), with fourteen total receptors divided into either A- or B-subclasses: EPHA (1-8 and 10) and EPHB (1-4 and 6). EPH receptors can have overlapping functions, and loss of one receptor can be partially compensated for by another EPH receptor that has similar expression pattern and ligand-binding specificities. EPH receptors have an N-terminal extracellular domain through which they bind to ephrin ligands, a short transmembrane domain, and an intracellular cytoplasmic signaling structure containing a canonical tyrosine kinase catalytic domain as well as other protein interaction sites. Ephrins are also sub-divided into an A-subclass (A1-A5), which are tethered to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor, and a B-subclass (B1-B3), members of which have a transmembrane domain and a short, highly conserved cytoplasmic tail lacking endogenous catalytic activity. The interaction between EPH receptors and its ligands requires cell-cell interaction since both molecules are membrane-bound. Close contact between EPH receptors and EFNs is required for signaling to occur. EPH/EFN-initiated signaling occurs bi-directionally into either EPH- or EFN-expressing cells or axons. Signaling into the EPH receptor-expressing cell is referred as the forward signal and signaling into the EFN-expressing cell, the reverse signal. (Dalva et al. 2000, Grunwald et al. 2004, Davy & Robbins 2000, Cowan et al. 2004)
FIG4 ProteinQ92562 (Uniprot-TrEMBL)
G3PMetaboliteCHEBI:15978 (ChEBI)
GDE1ProteinQ9NZC3 (Uniprot-TrEMBL)
GDPD1ProteinQ8N9F7 (Uniprot-TrEMBL)
GDPD3ProteinQ7L5L3 (Uniprot-TrEMBL)
GDPD5ProteinQ8WTR4 (Uniprot-TrEMBL)
GPChoMetaboliteCHEBI:16870 (ChEBI)
GTP MetaboliteCHEBI:15996 (ChEBI)
GroPInsMetaboliteCHEBI:58444 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
INPP4A ProteinQ96PE3 (Uniprot-TrEMBL)
INPP4A/BComplexR-HSA-1806281 (Reactome)
INPP4B ProteinO15327 (Uniprot-TrEMBL)
INPP5(1) R-HSA-1806201 (Reactome)
INPP5(2)ComplexR-HSA-1806186 (Reactome)
INPP5D ProteinQ92835 (Uniprot-TrEMBL)
INPP5E ProteinQ9NRR6 (Uniprot-TrEMBL)
INPP5FProteinQ9Y2H2 (Uniprot-TrEMBL)
INPP5J ProteinQ15735 (Uniprot-TrEMBL)
INPP5K ProteinQ9BT40 (Uniprot-TrEMBL)
INPPL1 ProteinO15357 (Uniprot-TrEMBL)
InsMetaboliteCHEBI:17268 (ChEBI)
LCFA(-)MetaboliteCHEBI:57560 (ChEBI)
LysoPtdChoMetaboliteCHEBI:58168 (ChEBI)
MAGMetaboliteCHEBI:17408 (ChEBI)
MTM1 ProteinQ13496 (Uniprot-TrEMBL)
MTM1,MTMR1,MTMR3,MTMR6,MTMR14,SYNJ1,SYNJ2ComplexR-HSA-1806223 (Reactome)
MTM1,MTMR2,MTMR4,MTMR7ComplexR-HSA-1806231 (Reactome)
MTM1,MTMR2,MTMR4ComplexR-HSA-1806263 (Reactome)
MTM1:MTMR12ComplexR-HSA-6809679 (Reactome)
MTM1ProteinQ13496 (Uniprot-TrEMBL)
MTMR1 ProteinQ13613 (Uniprot-TrEMBL)
MTMR10 ProteinQ9NXD2 (Uniprot-TrEMBL)
MTMR10ProteinQ9NXD2 (Uniprot-TrEMBL)
MTMR12 ProteinQ9C0I1 (Uniprot-TrEMBL)
MTMR12ProteinQ9C0I1 (Uniprot-TrEMBL)
MTMR14 ProteinQ8NCE2 (Uniprot-TrEMBL)
MTMR2 ProteinQ13614 (Uniprot-TrEMBL)
MTMR2 homodimerComplexR-HSA-6809787 (Reactome)
MTMR2:MTMR10ComplexR-HSA-6810024 (Reactome)
MTMR2:MTMR12ComplexR-HSA-6809705 (Reactome)
MTMR2:SBF1ComplexR-HSA-6809761 (Reactome)
MTMR2:SBF2 TetramerComplexR-HSA-6809791 (Reactome)
MTMR2ProteinQ13614 (Uniprot-TrEMBL)
MTMR3 ProteinQ13615 (Uniprot-TrEMBL)
MTMR4 ProteinQ9NYA4 (Uniprot-TrEMBL)
MTMR6 ProteinQ9Y217 (Uniprot-TrEMBL)
MTMR6:MTMR9,MTMR8:MTMR9ComplexR-HSA-6809318 (Reactome)
MTMR6:MTMR9ComplexR-HSA-6809246 (Reactome)
MTMR6ProteinQ9Y217 (Uniprot-TrEMBL)
MTMR7 ProteinQ9Y216 (Uniprot-TrEMBL)
MTMR7:MTMR9ComplexR-HSA-6809241 (Reactome)
MTMR7ProteinQ9Y216 (Uniprot-TrEMBL)
MTMR8 ProteinQ96EF0 (Uniprot-TrEMBL)
MTMR8:MTMR9ComplexR-HSA-6809252 (Reactome)
MTMR8ProteinQ96EF0 (Uniprot-TrEMBL)
MTMR9 ProteinQ96QG7 (Uniprot-TrEMBL)
MTMR9ProteinQ96QG7 (Uniprot-TrEMBL)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
Mn2+ MetaboliteCHEBI:29035 (ChEBI)
OCRL ProteinQ01968 (Uniprot-TrEMBL)
OCRL/INPP5EComplexR-HSA-1806215 (Reactome)
PC MetaboliteCHEBI:16110 (ChEBI)
PC:PITPNBComplexR-HSA-1524110 (Reactome)
PC:PITPNBComplexR-HSA-1524122 (Reactome)
PCMetaboliteCHEBI:16110 (ChEBI)
PI MetaboliteCHEBI:16749 (ChEBI)
PI(3,4)P2 MetaboliteCHEBI:16152 (ChEBI)
PI(3,4)P2MetaboliteCHEBI:16152 (ChEBI)
PI(3,4,5)P3 MetaboliteCHEBI:16618 (ChEBI)
PI(3,4,5)P3MetaboliteCHEBI:16618 (ChEBI)
PI(3,5)P2 MetaboliteCHEBI:16851 (ChEBI)
PI(3,5)P2MetaboliteCHEBI:16851 (ChEBI)
PI(4,5)P2 MetaboliteCHEBI:18348 (ChEBI)
PI(4,5)P2,

PI(3,4)P2,

PI(3,4,5)P3
ComplexR-ALL-8849959 (Reactome)
PI(4,5)P2, PI(3,4,5)P3ComplexR-ALL-8874460 (Reactome)
PI(4,5)P2, PI(3,4,5)P3ComplexR-ALL-8874484 (Reactome)
PI(4,5)P2MetaboliteCHEBI:18348 (ChEBI)
PI3P MetaboliteCHEBI:17283 (ChEBI)
PI3PMetaboliteCHEBI:17283 (ChEBI)
PI3PMetaboliteCHEBI:26034 (ChEBI)
PI4K2A ProteinQ9BTU6 (Uniprot-TrEMBL)
PI4K2A/2BComplexR-HSA-1806167 (Reactome)
PI4K2B ProteinQ8TCG2 (Uniprot-TrEMBL)
PI4KA ProteinP42356 (Uniprot-TrEMBL)
PI4KA/2A/2BComplexR-HSA-1806171 (Reactome)
PI4KA/2BComplexR-HSA-1806271 (Reactome)
PI4KB ProteinQ9UBF8 (Uniprot-TrEMBL)
PI4KBProteinQ9UBF8 (Uniprot-TrEMBL)
PI4P MetaboliteCHEBI:17526 (ChEBI)
PI4PMetaboliteCHEBI:17526 (ChEBI)
PI5P MetaboliteCHEBI:16500 (ChEBI)
PI5P, PI3P, PI(3,5)P2ComplexR-ALL-8849958 (Reactome)
PI5PMetaboliteCHEBI:16500 (ChEBI)
PI:PITPNBComplexR-HSA-1524117 (Reactome)
PI:PITPNBComplexR-HSA-1524150 (Reactome)
PIMetaboliteCHEBI:16749 (ChEBI)
PIK3(2)ComplexR-HSA-1806189 (Reactome)
PIK3C(1)ComplexR-HSA-1806233 (Reactome)
PIK3C2A ProteinO00443 (Uniprot-TrEMBL)
PIK3C2A/3ComplexR-HSA-1806185 (Reactome)
PIK3C2A/GComplexR-HSA-1806247 (Reactome)
PIK3C2A:Ca2+/Mg2+ComplexR-HSA-1604655 (Reactome)
PIK3C2B ProteinO00750 (Uniprot-TrEMBL)
PIK3C2G ProteinO75747 (Uniprot-TrEMBL)
PIK3C3 ProteinQ8NEB9 (Uniprot-TrEMBL)
PIK3CA ProteinP42336 (Uniprot-TrEMBL)
PIK3CB ProteinP42338 (Uniprot-TrEMBL)
PIK3CD ProteinO00329 (Uniprot-TrEMBL)
PIK3CG ProteinP48736 (Uniprot-TrEMBL)
PIK3R1 ProteinP27986 (Uniprot-TrEMBL)
PIK3R2 ProteinO00459 (Uniprot-TrEMBL)
PIK3R3 ProteinQ92569 (Uniprot-TrEMBL)
PIK3R4 ProteinQ99570 (Uniprot-TrEMBL)
PIK3R5 ProteinQ8WYR1 (Uniprot-TrEMBL)
PIK3R6 ProteinQ5UE93 (Uniprot-TrEMBL)
PIKFYVE ProteinQ9Y2I7 (Uniprot-TrEMBL)
PIKFYVE:VAC14:FIG4ComplexR-HSA-1806169 (Reactome)
PIKFYVE:VAC14:FIG4ComplexR-HSA-1806187 (Reactome)
PIKFYVE:VAC14:FIG4ComplexR-HSA-1806269 (Reactome)
PIP3 activates AKT signalingPathwayR-HSA-1257604 (Reactome) Signaling by AKT is one of the key outcomes of receptor tyrosine kinase (RTK) activation. AKT is activated by the cellular second messenger PIP3, a phospholipid that is generated by PI3K. In ustimulated cells, PI3K class IA enzymes reside in the cytosol as inactive heterodimers composed of p85 regulatory subunit and p110 catalytic subunit. In this complex, p85 stabilizes p110 while inhibiting its catalytic activity. Upon binding of extracellular ligands to RTKs, receptors dimerize and undergo autophosphorylation. The regulatory subunit of PI3K, p85, is recruited to phosphorylated cytosolic RTK domains either directly or indirectly, through adaptor proteins, leading to a conformational change in the PI3K IA heterodimer that relieves inhibition of the p110 catalytic subunit. Activated PI3K IA phosphorylates PIP2, converting it to PIP3; this reaction is negatively regulated by PTEN phosphatase. PIP3 recruits AKT to the plasma membrane, allowing TORC2 to phosphorylate a conserved serine residue of AKT. Phosphorylation of this serine induces a conformation change in AKT, exposing a conserved threonine residue that is then phosphorylated by PDPK1 (PDK1). Phosphorylation of both the threonine and the serine residue is required to fully activate AKT. The active AKT then dissociates from PIP3 and phosphorylates a number of cytosolic and nuclear proteins that play important roles in cell survival and metabolism. For a recent review of AKT signaling, please refer to Manning and Cantley, 2007.
PIP4K2 dimersComplexR-HSA-1806229 (Reactome)
PIP4K2 dimersComplexR-HSA-6811466 (Reactome)
PIP4K2/5K1ComplexR-HSA-1806163 (Reactome)
PIP4K2A ProteinP48426 (Uniprot-TrEMBL)
PIP4K2B ProteinP78356 (Uniprot-TrEMBL)
PIP4K2C ProteinQ8TBX8 (Uniprot-TrEMBL)
PIP5K1A ProteinQ99755 (Uniprot-TrEMBL)
PIP5K1A-CComplexR-HSA-1806157 (Reactome)
PIP5K1A/BComplexR-HSA-1806245 (Reactome)
PIP5K1B ProteinO14986 (Uniprot-TrEMBL)
PIP5K1C ProteinO60331 (Uniprot-TrEMBL)
PITPNB ProteinP48739 (Uniprot-TrEMBL)
PLEKHA1 ProteinQ9HB21 (Uniprot-TrEMBL)
PLEKHA2 ProteinQ9HB19 (Uniprot-TrEMBL)
PLEKHA3 ProteinQ9HB20 (Uniprot-TrEMBL)
PLEKHA3,8ComplexR-HSA-8870506 (Reactome)
PLEKHA4 ProteinQ9H4M7 (Uniprot-TrEMBL)
PLEKHA4,(5,6):PI3PComplexR-HSA-8870509 (Reactome)
PLEKHA4,(5,6)ComplexR-HSA-8870496 (Reactome)
PLEKHA5 ProteinQ9HAU0 (Uniprot-TrEMBL)
PLEKHA6 ProteinQ9Y2H5 (Uniprot-TrEMBL)
PLEKHA8 ProteinQ96JA3 (Uniprot-TrEMBL)
PNPLA6ProteinQ8IY17 (Uniprot-TrEMBL)
PNPLA7ProteinQ6ZV29 (Uniprot-TrEMBL)
PTENProteinP60484 (Uniprot-TrEMBL)
PTPN13 ProteinQ12923 (Uniprot-TrEMBL)
PTPN13:PLEKHA1,2:PIP2ComplexR-HSA-8870324 (Reactome)
PTPN13:PLEKHA1,2ComplexR-HSA-8870330 (Reactome)
PiMetaboliteCHEBI:18367 (ChEBI)
RAB14 ProteinP61106 (Uniprot-TrEMBL)
RAB14:GTPComplexR-HSA-8871377 (Reactome)
RAB4A ProteinP20338 (Uniprot-TrEMBL)
RAB4A:GTPComplexR-HSA-8871367 (Reactome)
RAB5A ProteinP20339 (Uniprot-TrEMBL)
RAB5A:GTPComplexR-HSA-2130191 (Reactome)
RUFY1ProteinQ96T51 (Uniprot-TrEMBL)
Regulation of TP53

Activity through

Acetylation
PathwayR-HSA-6804758 (Reactome) Transcriptional activity of TP53 is positively regulated by acetylation of several of its lysine residues. BRD7 binds TP53 and promotes acetylation of TP53 lysine residue K382 by acetyltransferase EP300 (p300). Acetylation of K382 enhances TP53 binding to target promoters, including CDKN1A (p21), MDM2, SERPINE1, TIGAR, TNFRSF10C and NDRG1 (Bensaad et al. 2010, Burrows et al. 2010. Drost et al. 2010). The histone acetyltransferase KAT6A, in the presence of PML, also acetylates TP53 at K382, and, in addition, acetylates K120 of TP53. KAT6A-mediated acetylation increases transcriptional activation of CDKN1A by TP53 (Rokudai et al. 2013). Acetylation of K382 can be reversed by the action of the NuRD complex, containing the TP53-binding MTA2 subunit, resulting in inhibition of TP53 transcriptional activity (Luo et al. 2000). Acetylation of lysine K120 in the DNA binding domain of TP53 by the MYST family acetyltransferases KAT8 (hMOF) and KAT5 (TIP60) can modulate the decision between cell cycle arrest and apoptosis (Sykes et al. 2006, Tang et al. 2006). Studies with acetylation-defective knock-in mutant mice indicate that lysine acetylation in the p53 DNA binding domain acts in part by uncoupling transactivation and transrepression of gene targets, while retaining ability to modulate energy metabolism and production of reactive oxygen species (ROS) and influencing ferroptosis (Li et al. 2012, Jiang et al. 2015).
SACM1LProteinQ9NTJ5 (Uniprot-TrEMBL)
SBF1 ProteinO95248 (Uniprot-TrEMBL)
SBF1ProteinO95248 (Uniprot-TrEMBL)
SBF2 ProteinQ86WG5 (Uniprot-TrEMBL)
SBF2 homodimerComplexR-HSA-6809794 (Reactome)
SYNJ/INPP5(1)ComplexR-HSA-1806214 (Reactome)
SYNJ1 ProteinO43426 (Uniprot-TrEMBL)
SYNJ2 ProteinO15056 (Uniprot-TrEMBL)
SYNJs,OCRLComplexR-HSA-1806173 (Reactome)
TCR signalingPathwayR-HSA-202403 (Reactome) The TCR is a multisubunit complex that consists of clonotypic alpha/beta chains noncovalently associated with the invariant CD3 delta/epsilon/gamma and TCR zeta chains. T cell activation by antigen presenting cells (APCs) results in the activation of protein tyrosine kinases (PTKs) that associate with CD3 and TCR zeta subunits and the co-receptor CD4. Members of the Src kinases (Lck), Syk kinases (ZAP-70), Tec (Itk) and Csk families of nonreceptor PTKs play a crucial role in T cell activation. Activation of PTKs following TCR engagement results in the recruitment and tyrosine phosphorylation of enzymes such as phospholipase C gamma1 and Vav as well as critical adaptor proteins such as LAT, SLP-76 and Gads. These proximal activation leads to reorganization of the cytoskeleton as well as transcription activation of multiple genes leading to T lymphocyte proliferation, differentiation and/or effector function.
TMEM55BProteinQ86T03 (Uniprot-TrEMBL)
TNFAIP8 ProteinO95379 (Uniprot-TrEMBL)
TNFAIP8 proteinsComplexR-HSA-8874488 (Reactome)
TNFAIP8L1 ProteinQ8WVP5 (Uniprot-TrEMBL)
TNFAIP8L2 ProteinQ6P589 (Uniprot-TrEMBL)
TNFAIP8L3 ProteinQ5GJ75 (Uniprot-TrEMBL)
TPTE ProteinP56180 (Uniprot-TrEMBL)
TPTE2 ProteinQ6XPS3 (Uniprot-TrEMBL)
TPTE2-like proteinsComplexR-HSA-3968346 (Reactome) This CandidateSet contains sequences identified by William Pearson's analysis of Reactome catalyst entities. Catalyst entity sequences were used to identify analagous sequences that shared overall homology and active site homology. Sequences in this Candidate set were identified in an April 24, 2012 analysis.
VAC14 ProteinQ08AM6 (Uniprot-TrEMBL)
lysophosphatidylcholineMetaboliteCHEBI:60479 (ChEBI)
p-Y281,292-RUFY1 ProteinQ96T51 (Uniprot-TrEMBL)
p-Y281,292-RUFY1:PI3PComplexR-HSA-8871354 (Reactome)
p-Y281,292-RUFY1:p-Y281,292-RUFY1:RAB4A:GTP:RAB5:GTP:RAB14:GTPComplexR-HSA-8871353 (Reactome)
p-Y281,292-RUFY1ProteinQ96T51 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ADPArrowR-HSA-1675773 (Reactome)
ADPArrowR-HSA-1675776 (Reactome)
ADPArrowR-HSA-1675780 (Reactome)
ADPArrowR-HSA-1675810 (Reactome)
ADPArrowR-HSA-1675813 (Reactome)
ADPArrowR-HSA-1675866 (Reactome)
ADPArrowR-HSA-1675883 (Reactome)
ADPArrowR-HSA-1675910 (Reactome)
ADPArrowR-HSA-1675921 (Reactome)
ADPArrowR-HSA-1675928 (Reactome)
ADPArrowR-HSA-1675939 (Reactome)
ADPArrowR-HSA-1675961 (Reactome)
ADPArrowR-HSA-1675974 (Reactome)
ADPArrowR-HSA-1676024 (Reactome)
ADPArrowR-HSA-1676048 (Reactome)
ADPArrowR-HSA-1676082 (Reactome)
ADPArrowR-HSA-1676109 (Reactome)
ADPArrowR-HSA-1676134 (Reactome)
ADPArrowR-HSA-1676145 (Reactome)
ADPArrowR-HSA-1676168 (Reactome)
ADPArrowR-HSA-1676185 (Reactome)
ADPArrowR-HSA-1676206 (Reactome)
ADPArrowR-HSA-6811522 (Reactome)
ADPArrowR-HSA-8871373 (Reactome)
ARF1/3:GTP:PI4KBArrowR-HSA-1676152 (Reactome)
ARF1/3:GTP:PI4KBmim-catalysisR-HSA-1675883 (Reactome)
ARF1/3:GTPR-HSA-1676152 (Reactome)
ARF1:PLEKHA3,8:PI4PArrowR-HSA-8870499 (Reactome)
ARF1R-HSA-8870499 (Reactome)
ATPR-HSA-1675773 (Reactome)
ATPR-HSA-1675776 (Reactome)
ATPR-HSA-1675780 (Reactome)
ATPR-HSA-1675810 (Reactome)
ATPR-HSA-1675813 (Reactome)
ATPR-HSA-1675866 (Reactome)
ATPR-HSA-1675883 (Reactome)
ATPR-HSA-1675910 (Reactome)
ATPR-HSA-1675921 (Reactome)
ATPR-HSA-1675928 (Reactome)
ATPR-HSA-1675939 (Reactome)
ATPR-HSA-1675961 (Reactome)
ATPR-HSA-1675974 (Reactome)
ATPR-HSA-1676024 (Reactome)
ATPR-HSA-1676048 (Reactome)
ATPR-HSA-1676082 (Reactome)
ATPR-HSA-1676109 (Reactome)
ATPR-HSA-1676134 (Reactome)
ATPR-HSA-1676145 (Reactome)
ATPR-HSA-1676168 (Reactome)
ATPR-HSA-1676185 (Reactome)
ATPR-HSA-1676206 (Reactome)
ATPR-HSA-6811522 (Reactome)
ATPR-HSA-8871373 (Reactome)
BMXmim-catalysisR-HSA-8871373 (Reactome)
ChoArrowR-HSA-6814132 (Reactome)
ChoPArrowR-HSA-6814797 (Reactome)
ENPP6mim-catalysisR-HSA-6814797 (Reactome)
G3PArrowR-HSA-6813740 (Reactome)
G3PArrowR-HSA-6814132 (Reactome)
GDE1mim-catalysisR-HSA-6813740 (Reactome)
GDPD1mim-catalysisR-HSA-6814766 (Reactome)
GDPD3mim-catalysisR-HSA-6814778 (Reactome)
GDPD5mim-catalysisR-HSA-6814132 (Reactome)
GPChoArrowR-HSA-6814254 (Reactome)
GPChoArrowR-HSA-6814766 (Reactome)
GPChoArrowR-HSA-6814778 (Reactome)
GPChoArrowR-HSA-8847912 (Reactome)
GPChoR-HSA-6814132 (Reactome)
GroPInsR-HSA-6813740 (Reactome)
H2OR-HSA-1675795 (Reactome)
H2OR-HSA-1675824 (Reactome)
H2OR-HSA-1675836 (Reactome)
H2OR-HSA-1675949 (Reactome)
H2OR-HSA-1675988 (Reactome)
H2OR-HSA-1675994 (Reactome)
H2OR-HSA-1676005 (Reactome)
H2OR-HSA-1676020 (Reactome)
H2OR-HSA-1676065 (Reactome)
H2OR-HSA-1676105 (Reactome)
H2OR-HSA-1676114 (Reactome)
H2OR-HSA-1676124 (Reactome)
H2OR-HSA-1676141 (Reactome)
H2OR-HSA-1676149 (Reactome)
H2OR-HSA-1676162 (Reactome)
H2OR-HSA-1676164 (Reactome)
H2OR-HSA-1676174 (Reactome)
H2OR-HSA-1676177 (Reactome)
H2OR-HSA-1676203 (Reactome)
H2OR-HSA-1676204 (Reactome)
H2OR-HSA-199456 (Reactome)
H2OR-HSA-6809320 (Reactome)
H2OR-HSA-6809325 (Reactome)
H2OR-HSA-6809720 (Reactome)
H2OR-HSA-6809777 (Reactome)
H2OR-HSA-6809778 (Reactome)
H2OR-HSA-6809944 (Reactome)
H2OR-HSA-6809975 (Reactome)
H2OR-HSA-6810410 (Reactome)
H2OR-HSA-6813740 (Reactome)
H2OR-HSA-6814132 (Reactome)
H2OR-HSA-6814254 (Reactome)
H2OR-HSA-6814766 (Reactome)
H2OR-HSA-6814778 (Reactome)
H2OR-HSA-6814797 (Reactome)
H2OR-HSA-8847912 (Reactome)
H2OR-HSA-8849969 (Reactome)
INPP4A/Bmim-catalysisR-HSA-1676162 (Reactome)
INPP4A/Bmim-catalysisR-HSA-1676164 (Reactome)
INPP5(2)mim-catalysisR-HSA-1675949 (Reactome)
INPP5Fmim-catalysisR-HSA-8849969 (Reactome)
InsArrowR-HSA-6813740 (Reactome)
LCFA(-)ArrowR-HSA-6814254 (Reactome)
LCFA(-)ArrowR-HSA-6814766 (Reactome)
LCFA(-)ArrowR-HSA-6814778 (Reactome)
LCFA(-)ArrowR-HSA-8847912 (Reactome)
LysoPtdChoR-HSA-6814254 (Reactome)
LysoPtdChoR-HSA-6814766 (Reactome)
LysoPtdChoR-HSA-6814778 (Reactome)
LysoPtdChoR-HSA-8847912 (Reactome)
MAGArrowR-HSA-6814797 (Reactome)
MTM1,MTMR1,MTMR3,MTMR6,MTMR14,SYNJ1,SYNJ2mim-catalysisR-HSA-1675994 (Reactome)
MTM1,MTMR1,MTMR3,MTMR6,MTMR14,SYNJ1,SYNJ2mim-catalysisR-HSA-1676203 (Reactome)
MTM1,MTMR2,MTMR4,MTMR7mim-catalysisR-HSA-1675795 (Reactome)
MTM1,MTMR2,MTMR4,MTMR7mim-catalysisR-HSA-1676065 (Reactome)
MTM1,MTMR2,MTMR4mim-catalysisR-HSA-1676105 (Reactome)
MTM1,MTMR2,MTMR4mim-catalysisR-HSA-1676141 (Reactome)
MTM1:MTMR12ArrowR-HSA-6809680 (Reactome)
MTM1:MTMR12mim-catalysisR-HSA-6809720 (Reactome)
MTM1R-HSA-6809680 (Reactome)
MTMR10R-HSA-6810030 (Reactome)
MTMR12R-HSA-6809680 (Reactome)
MTMR12R-HSA-6809707 (Reactome)
MTMR2 homodimerArrowR-HSA-6809785 (Reactome)
MTMR2 homodimerR-HSA-6809793 (Reactome)
MTMR2:MTMR10ArrowR-HSA-6810030 (Reactome)
MTMR2:MTMR12ArrowR-HSA-6809707 (Reactome)
MTMR2:SBF1ArrowR-HSA-6809764 (Reactome)
MTMR2:SBF1mim-catalysisR-HSA-6809777 (Reactome)
MTMR2:SBF1mim-catalysisR-HSA-6809778 (Reactome)
MTMR2:SBF2 TetramerArrowR-HSA-6809793 (Reactome)
MTMR2:SBF2 Tetramermim-catalysisR-HSA-6809944 (Reactome)
MTMR2:SBF2 Tetramermim-catalysisR-HSA-6809975 (Reactome)
MTMR2R-HSA-6809707 (Reactome)
MTMR2R-HSA-6809764 (Reactome)
MTMR2R-HSA-6809785 (Reactome)
MTMR2R-HSA-6810030 (Reactome)
MTMR6:MTMR9,MTMR8:MTMR9mim-catalysisR-HSA-6809320 (Reactome)
MTMR6:MTMR9,MTMR8:MTMR9mim-catalysisR-HSA-6809325 (Reactome)
MTMR6:MTMR9ArrowR-HSA-6809309 (Reactome)
MTMR6R-HSA-6809309 (Reactome)
MTMR7:MTMR9ArrowR-HSA-6809238 (Reactome)
MTMR7R-HSA-6809238 (Reactome)
MTMR8:MTMR9ArrowR-HSA-6809254 (Reactome)
MTMR8R-HSA-6809254 (Reactome)
MTMR9R-HSA-6809238 (Reactome)
MTMR9R-HSA-6809254 (Reactome)
MTMR9R-HSA-6809309 (Reactome)
OCRL/INPP5Emim-catalysisR-HSA-1675824 (Reactome)
PC:PITPNBArrowR-HSA-1483087 (Reactome)
PC:PITPNBArrowR-HSA-1483211 (Reactome)
PC:PITPNBR-HSA-1483211 (Reactome)
PC:PITPNBR-HSA-1483219 (Reactome)
PCArrowR-HSA-1483219 (Reactome)
PCR-HSA-1483087 (Reactome)
PI(3,4)P2ArrowR-HSA-1675834 (Reactome)
PI(3,4)P2ArrowR-HSA-1675928 (Reactome)
PI(3,4)P2ArrowR-HSA-1675949 (Reactome)
PI(3,4)P2ArrowR-HSA-1676109 (Reactome)
PI(3,4)P2ArrowR-HSA-1676145 (Reactome)
PI(3,4)P2ArrowR-HSA-1676206 (Reactome)
PI(3,4)P2R-HSA-1675773 (Reactome)
PI(3,4)P2R-HSA-1675834 (Reactome)
PI(3,4)P2R-HSA-1676149 (Reactome)
PI(3,4)P2R-HSA-1676162 (Reactome)
PI(3,4)P2R-HSA-1676164 (Reactome)
PI(3,4)P2R-HSA-1676204 (Reactome)
PI(3,4)P2R-HSA-8870332 (Reactome)
PI(3,4,5)P3ArrowR-HSA-1675773 (Reactome)
PI(3,4,5)P3ArrowR-HSA-1676048 (Reactome)
PI(3,4,5)P3R-HSA-1675949 (Reactome)
PI(3,4,5)P3R-HSA-199456 (Reactome)
PI(3,5)P2ArrowR-HSA-1675896 (Reactome)
PI(3,5)P2ArrowR-HSA-1675910 (Reactome)
PI(3,5)P2ArrowR-HSA-1675921 (Reactome)
PI(3,5)P2ArrowR-HSA-1676041 (Reactome)
PI(3,5)P2ArrowR-HSA-1676134 (Reactome)
PI(3,5)P2ArrowR-HSA-1676161 (Reactome)
PI(3,5)P2ArrowR-HSA-1676168 (Reactome)
PI(3,5)P2R-HSA-1675836 (Reactome)
PI(3,5)P2R-HSA-1675896 (Reactome)
PI(3,5)P2R-HSA-1676005 (Reactome)
PI(3,5)P2R-HSA-1676020 (Reactome)
PI(3,5)P2R-HSA-1676041 (Reactome)
PI(3,5)P2R-HSA-1676065 (Reactome)
PI(3,5)P2R-HSA-1676105 (Reactome)
PI(3,5)P2R-HSA-1676161 (Reactome)
PI(3,5)P2R-HSA-1676174 (Reactome)
PI(3,5)P2R-HSA-1676203 (Reactome)
PI(3,5)P2R-HSA-6809320 (Reactome)
PI(3,5)P2R-HSA-6809778 (Reactome)
PI(3,5)P2R-HSA-6809944 (Reactome)
PI(4,5)P2,

PI(3,4)P2,

PI(3,4,5)P3
R-HSA-8849969 (Reactome)
PI(4,5)P2, PI(3,4,5)P3ArrowR-HSA-8874470 (Reactome)
PI(4,5)P2, PI(3,4,5)P3R-HSA-8874470 (Reactome)
PI(4,5)P2ArrowR-HSA-1675776 (Reactome)
PI(4,5)P2ArrowR-HSA-1676082 (Reactome)
PI(4,5)P2ArrowR-HSA-199456 (Reactome)
PI(4,5)P2ArrowR-HSA-6811522 (Reactome)
PI(4,5)P2R-HSA-1675824 (Reactome)
PI(4,5)P2R-HSA-1676048 (Reactome)
PI(4,5)P2R-HSA-1676177 (Reactome)
PI(4,5)P2R-HSA-6810410 (Reactome)
PI3PArrowR-HSA-1675836 (Reactome)
PI3PArrowR-HSA-1675939 (Reactome)
PI3PArrowR-HSA-1675961 (Reactome)
PI3PArrowR-HSA-1676005 (Reactome)
PI3PArrowR-HSA-1676020 (Reactome)
PI3PArrowR-HSA-1676024 (Reactome)
PI3PArrowR-HSA-1676162 (Reactome)
PI3PArrowR-HSA-1676164 (Reactome)
PI3PArrowR-HSA-1676174 (Reactome)
PI3PR-HSA-1675795 (Reactome)
PI3PR-HSA-1675910 (Reactome)
PI3PR-HSA-1675921 (Reactome)
PI3PR-HSA-1675994 (Reactome)
PI3PR-HSA-1676114 (Reactome)
PI3PR-HSA-1676134 (Reactome)
PI3PR-HSA-1676141 (Reactome)
PI3PR-HSA-1676145 (Reactome)
PI3PR-HSA-1676168 (Reactome)
PI3PR-HSA-6809325 (Reactome)
PI3PR-HSA-6809720 (Reactome)
PI3PR-HSA-6809777 (Reactome)
PI3PR-HSA-6809975 (Reactome)
PI3PR-HSA-8870489 (Reactome)
PI3PR-HSA-8871376 (Reactome)
PI4K2A/2Bmim-catalysisR-HSA-1675780 (Reactome)
PI4K2A/2Bmim-catalysisR-HSA-1675974 (Reactome)
PI4KA/2A/2Bmim-catalysisR-HSA-1676185 (Reactome)
PI4KA/2Bmim-catalysisR-HSA-1675813 (Reactome)
PI4KBR-HSA-1676152 (Reactome)
PI4PArrowR-HSA-1675780 (Reactome)
PI4PArrowR-HSA-1675813 (Reactome)
PI4PArrowR-HSA-1675815 (Reactome)
PI4PArrowR-HSA-1675824 (Reactome)
PI4PArrowR-HSA-1675883 (Reactome)
PI4PArrowR-HSA-1675974 (Reactome)
PI4PArrowR-HSA-1676149 (Reactome)
PI4PArrowR-HSA-1676177 (Reactome)
PI4PArrowR-HSA-1676185 (Reactome)
PI4PArrowR-HSA-1676204 (Reactome)
PI4PR-HSA-1675815 (Reactome)
PI4PR-HSA-1675928 (Reactome)
PI4PR-HSA-1675988 (Reactome)
PI4PR-HSA-1676082 (Reactome)
PI4PR-HSA-1676109 (Reactome)
PI4PR-HSA-1676124 (Reactome)
PI4PR-HSA-1676133 (Reactome)
PI4PR-HSA-1676206 (Reactome)
PI4PR-HSA-8870499 (Reactome)
PI5P, PI3P, PI(3,5)P2ArrowR-HSA-8849969 (Reactome)
PI5PArrowR-HSA-1675810 (Reactome)
PI5PArrowR-HSA-1675866 (Reactome)
PI5PArrowR-HSA-1676065 (Reactome)
PI5PArrowR-HSA-1676105 (Reactome)
PI5PArrowR-HSA-1676203 (Reactome)
PI5PArrowR-HSA-6809320 (Reactome)
PI5PArrowR-HSA-6809778 (Reactome)
PI5PArrowR-HSA-6809944 (Reactome)
PI5PArrowR-HSA-6810410 (Reactome)
PI5PR-HSA-1675776 (Reactome)
PI5PR-HSA-6811522 (Reactome)
PI:PITPNBArrowR-HSA-1483219 (Reactome)
PI:PITPNBArrowR-HSA-1483229 (Reactome)
PI:PITPNBR-HSA-1483087 (Reactome)
PI:PITPNBR-HSA-1483229 (Reactome)
PIArrowR-HSA-1483087 (Reactome)
PIArrowR-HSA-1675795 (Reactome)
PIArrowR-HSA-1675988 (Reactome)
PIArrowR-HSA-1675994 (Reactome)
PIArrowR-HSA-1676114 (Reactome)
PIArrowR-HSA-1676124 (Reactome)
PIArrowR-HSA-1676133 (Reactome)
PIArrowR-HSA-1676141 (Reactome)
PIArrowR-HSA-6809325 (Reactome)
PIArrowR-HSA-6809720 (Reactome)
PIArrowR-HSA-6809777 (Reactome)
PIArrowR-HSA-6809975 (Reactome)
PIK3(2)mim-catalysisR-HSA-1676109 (Reactome)
PIK3C(1)mim-catalysisR-HSA-1676048 (Reactome)
PIK3C2A/3mim-catalysisR-HSA-1675939 (Reactome)
PIK3C2A/3mim-catalysisR-HSA-1675961 (Reactome)
PIK3C2A/3mim-catalysisR-HSA-1676024 (Reactome)
PIK3C2A/Gmim-catalysisR-HSA-1675928 (Reactome)
PIK3C2A:Ca2+/Mg2+mim-catalysisR-HSA-1676206 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1675866 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1675910 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1675921 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1676005 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1676020 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1676168 (Reactome)
PIKFYVE:VAC14:FIG4mim-catalysisR-HSA-1676174 (Reactome)
PIP4K2 dimersmim-catalysisR-HSA-1675776 (Reactome)
PIP4K2 dimersmim-catalysisR-HSA-6811522 (Reactome)
PIP4K2/5K1mim-catalysisR-HSA-1676145 (Reactome)
PIP5K1A-Cmim-catalysisR-HSA-1675773 (Reactome)
PIP5K1A-Cmim-catalysisR-HSA-1676082 (Reactome)
PIP5K1A/Bmim-catalysisR-HSA-1675810 (Reactome)
PIP5K1A/Bmim-catalysisR-HSA-1676134 (Reactome)
PIR-HSA-1483219 (Reactome)
PIR-HSA-1675780 (Reactome)
PIR-HSA-1675810 (Reactome)
PIR-HSA-1675813 (Reactome)
PIR-HSA-1675866 (Reactome)
PIR-HSA-1675883 (Reactome)
PIR-HSA-1675939 (Reactome)
PIR-HSA-1675961 (Reactome)
PIR-HSA-1675974 (Reactome)
PIR-HSA-1676024 (Reactome)
PIR-HSA-1676185 (Reactome)
PLEKHA3,8R-HSA-8870499 (Reactome)
PLEKHA4,(5,6):PI3PArrowR-HSA-8870489 (Reactome)
PLEKHA4,(5,6)R-HSA-8870489 (Reactome)
PNPLA6mim-catalysisR-HSA-6814254 (Reactome)
PNPLA7mim-catalysisR-HSA-8847912 (Reactome)
PTENmim-catalysisR-HSA-1676149 (Reactome)
PTENmim-catalysisR-HSA-199456 (Reactome)
PTPN13:PLEKHA1,2:PIP2ArrowR-HSA-8870332 (Reactome)
PTPN13:PLEKHA1,2R-HSA-8870332 (Reactome)
PiArrowR-HSA-1675795 (Reactome)
PiArrowR-HSA-1675824 (Reactome)
PiArrowR-HSA-1675836 (Reactome)
PiArrowR-HSA-1675949 (Reactome)
PiArrowR-HSA-1675988 (Reactome)
PiArrowR-HSA-1675994 (Reactome)
PiArrowR-HSA-1676005 (Reactome)
PiArrowR-HSA-1676020 (Reactome)
PiArrowR-HSA-1676065 (Reactome)
PiArrowR-HSA-1676105 (Reactome)
PiArrowR-HSA-1676114 (Reactome)
PiArrowR-HSA-1676124 (Reactome)
PiArrowR-HSA-1676133 (Reactome)
PiArrowR-HSA-1676141 (Reactome)
PiArrowR-HSA-1676149 (Reactome)
PiArrowR-HSA-1676162 (Reactome)
PiArrowR-HSA-1676164 (Reactome)
PiArrowR-HSA-1676174 (Reactome)
PiArrowR-HSA-1676177 (Reactome)
PiArrowR-HSA-1676203 (Reactome)
PiArrowR-HSA-1676204 (Reactome)
PiArrowR-HSA-199456 (Reactome)
PiArrowR-HSA-6809320 (Reactome)
PiArrowR-HSA-6809325 (Reactome)
PiArrowR-HSA-6809720 (Reactome)
PiArrowR-HSA-6809777 (Reactome)
PiArrowR-HSA-6809778 (Reactome)
PiArrowR-HSA-6809944 (Reactome)
PiArrowR-HSA-6809975 (Reactome)
PiArrowR-HSA-6810410 (Reactome)
PiArrowR-HSA-8849969 (Reactome)
R-HSA-1483087 (Reactome) At the Golgi membrane, phosphatidylinositol (PI) is exchanged for phosphatidylcholine (PC) within the phosphatidylinositol transfer protein beta isoform (PITPNB) complex (Tilley et al. 2004, Yolder et al. 2001, Carvou et al. 2010, Schouten et al. 2002, Vordtriede et al. 2005, Shadan et al. 2008).
R-HSA-1483211 (Reactome) The complex between phosphatidylcholine (PC) and phosphatidylinositol transfer protein beta isoform (PITPNB) transports from the Golgi membrane to the ER membrane (Carvou et al. 2010, Shadan et al. 2008).
R-HSA-1483219 (Reactome) At the ER membrane, phosphatidylcholine (PC) is exchanged for phosphatidylinositol (PI) within the phosphatidylinositol transfer protein beta isoform (PITPNB) complex (Tilley et al. 2004, Yolder et al. 2001, Carvou et al. 2010, Schouten et al. 2002, Vordtriede et al. 2005, Shadan et al. 2008).
R-HSA-1483229 (Reactome) The phosphatidylinositol transfer protein beta isoform (PITPNB) bound to phosphatidylinositol (PI) complex transports from the endoplasmic reticulum (ER) membrane to the Golgi membrane (Carvou et al. 2010, Shadan et al. 2008).
R-HSA-1675773 (Reactome) At the plasma membrane, phosphatidylinositol-4-phosphate 5-kinase type-1 alpha (PIP5K1A), beta (PIP5K1B), and gamma (PIP5K1C) phosphorylate phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) to produce phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). This is a minor reaction, however, and its physiological role is uncertain.

The following lists the above proteins with their corresponding literature references: PIP5K1A (Zhang et al. 1997, Tolias et al. 1998), PIP5K1B (Zhang et al. 1997, Tolias et al. 1998), and PIP5K1C (Wenk et al. 2001, Di Paolo et al. 2002, Krauss et al. 2003).
R-HSA-1675776 (Reactome) At the plasma membrane, phosphatidylinositol-5-phosphate 4-kinase type-2 alpha (PIP4K2A), beta (PIP4K2B) and gamma (PIP4K2C) homodimers and heterodimers (Clarke et al. 2010, Clarke and Irvine 2013, Clarke et al. 2015) phosphorylate phosphatidylinositol 5-phosphate (PI5P) to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2).

The following lists the above proteins with their corresponding literature references: PIP4K2A (Rameh et al. 1997, Clarke et al. 2008, Clarke and Irvine 2013), PIP4K2B (Rameh et al. 1997, Clarke and Irvine 2013) and PIP4K2C (Clarke and Irvine 2013, Clarke et al. 2015).
R-HSA-1675780 (Reactome) At the plasma membrane, phosphatidylinositol 4-kinase type 2-alpha (PI4K2A) (Balla et al. 2002, Minogue et al. 2001) and beta (PI4K2B) (Balla et al. 2002, Wei et al. 2002) phosphorylate phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P).
R-HSA-1675795 (Reactome) At the late endosome membrane, myotubularin (MTM1), myotubularin-related protein 2 (MTMR2), myotubularin-related protein 4 (MTMR4), and myotubularin-related protein 7 (MTMR7) dephosphorylate phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol (PI).

The following lists the above proteins with their corresponding literature references: MTM1 (Cao et al. 2007, Cao et al. 2008, Tsujita et al. 2004, Tronchere et al. 2004, Kim et al. 2002); MTMR2 (Cao et al. 2008, Kim et al. 2002); MTMR4 (Lorenzo et al. 2006); and MTMR7 (Mochizuki & Majerus 2003, Lorenzo et al. 2006).
R-HSA-1675810 (Reactome) At the plasma membrane, phosphatidylinositol-4-phosphate 5-kinase type-1 alpha (PIP5K1A) and beta (PIP5K1B) phosphorylate phosphatidylinositol (PI) to produce phosphatidylinositol 5-phosphate (PI5P) (Tolias et al. 1998).
R-HSA-1675813 (Reactome) At the endoplasmic reticulum (ER) membrane, phosphatidylinositol 4-kinase alpha (PI4KA) (Wong et al. 1997, Gehrmann et al. 1999) or phosphatidylinositol 4-kinase type 2-beta (PI4K2B) (Wei et al. 2002) phosphorylate phosphatidylinositol (PI) to produce phosphatidylinositol 4-phosphate (PI4P).
R-HSA-1675815 (Reactome) Phosphatidylinositol 4-phosphate (PI4P) translocates from the Golgi membrane to the plasma membrane via a secretory vesicle mechanism (Szentpetery et al. 2010, Godi et al. 2004, Hammond et al. 2009).
R-HSA-1675824 (Reactome) At the Golgi membrane, phosphatidylinositol 4-phosphate (PI4P) inositol polyphosphate 5-phosphatase OCRL-1 (OCRL) (Choudhury et al. 2009, Suchy et al. 1995, Zhang et al. 1995) and 72 kDa inositol polyphosphate 5-phosphatase (INPP5E) (Bilas et al. 2009) dephosphorylate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to form phosphatidylinositol 4-phosphate (PI4P). INPP5E is located in the Golgi membrane, mediated by its N-terminal proline-rich domain (Kong et al. 2000).
R-HSA-1675834 (Reactome) In mice, phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) translocates from the plasma membrane to the early endosome membrane (Watt et al. 2004). A similar event has also been detected in cells from Chlorocebus sabaeus (Green Monkey) (Ivetac et al. 2005). In humans this event is inferred from the other two occurrences.
R-HSA-1675836 (Reactome) At the plasma membrane, synaptic inositol-1,4,5-trisphosphate 5-phosphatase 1 aka synaptojanin-1 (SYNJ1) (Guo et al. 1999, Mani et al. 2007) and -2 (SYNJ2) (Malecz et al. 2000) dephosphorylate phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 3-phosphate (PI3P).
R-HSA-1675866 (Reactome) At the late endosome membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger. The PIKFYVE kinase component phosphorylates phosphatidylinositol (PI) to phosphatidylinositol 5-phosphate (PI5P) (Sbrissa et al. 1999, Sbrissa et al. 2002). The PAS complex is present in the cytosol and is recruited to the membrane.
R-HSA-1675883 (Reactome) At the Golgi membrane, activated phosphatidylinositol 4-kinase beta (PI4KB) complexed to ADP-ribosylation factor 1/3 (ARF1/3) phosphorylates phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P) (Suzuki et al. 1997).
R-HSA-1675896 (Reactome) Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) translocates from the early endosome membrane to the Golgi membrane (Rutherford et al. 2006).
R-HSA-1675910 (Reactome) At the late endosome membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger (Sbrissa et al. 2002, Cao et al. 2007). The PIKFYVE kinase component phosphorylates phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol 3,5-bisphosphate PI(3,5)P2 (Sbrissa et al. 1999). The PAS complex is present in the cytosol and is recruited to the membrane (Sbrissa et al. 2007).
R-HSA-1675921 (Reactome) At the Golgi membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger (Sbrissa et al. 2002). The PIKFYVE kinase component phosphorylates phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol 3,5-bisphosphate PI(3,5)P2 (Sbrissa et al. 1999, McEwen et al. 1999). The PAS complex is present in the cytosol and is recruited to the membrane (Sbrissa et al. 2007). VAC14 acts as a scaffolding protein via its C-terminal domain (Sbrissa et al. 2008).
R-HSA-1675928 (Reactome) At the Golgi membrane, phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) (Domin et al. 2000, Arcaro et al. 2000) and phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma (PIK3C2G) (Ono et al. 1998, Rozycka et al. 1998, Misawa et al. 1998) phosphorylate phosphatidylinositol 4-phosphate (PI4P) to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). PIK3C2G phosphorylates phosphatidylinositol (PI) and PI4P but not phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2).
R-HSA-1675939 (Reactome) At the early endosome membrane, phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) aka VPS34 binds to phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4). The PIK3C3:PIK3R4 complex and phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) phosphorylate phosphatidylinositol (PI) to phosphatidylinositol 3-phosphate (PI3P).

The following lists the above proteins with their corresponding literature references: PIK3C3:PIK3R4 complex (Panaretou et al. 1997, Volinia et al. 1995, Cao et al. 2007) and PIK3C2A (Arcaro et al. 2000, Domin et al. 2000).
R-HSA-1675949 (Reactome) At the plasma membrane, phosphatidylinositol 5-phosphatases dephosphorylate phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). The phosphatidylinositol 5-phosphatases involved are: inositol polyphosphate 5-phosphatase K (INPP5K) aka SKIP (Ijuin et al. 2000, Gurung et al. 2003), phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (INPP5J) aka PIPP (Gurung et al. 2003, Mochizuki & Takenawa 1999), phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 (INPP5D) aka SHIP1 (Drayer et al. 1995, Kavanaugh et al. 1996, Dunant et al. 2000), and phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2 (INPPL1) aka SHIP2 (Habib et al. 1998, Wisniewski et al. 1999, Pesesse et al. 2001).
R-HSA-1675961 (Reactome) At the Golgi membrane, phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) aka VPS34 is bound to phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4). This PIK3C3:PIK2R4 complex and phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) phosphorylate phosphatidylinositol (PI) to phosphatidylinositol 3-phosphate (PI3P).

The following lists the above proteins with their corresponding literature references: PIK3C3:PIK2R4 (Panaretou et al. 1997, Volinia et al. 1995) and PIK3C2A (Arcaro et al. 2000, Domin et al. 2000).
R-HSA-1675974 (Reactome) At the early endosome membrane, phosphatidylinositol 4-kinase type 2-alpha/beta (PI4K2A/B) (Balla et al. 2002) phosphorylates phosphatidylinositol (PI) to produce phosphatidylinositol 4-phosphate (PI4P).
R-HSA-1675988 (Reactome) At the plasma membrane, synaptic inositol-1,4,5-trisphosphate 5-phosphatase 1 aka Synaptojanin-1 (SYNJ1) (Guo et al. 1999, Mani et al. 2007, Johenning et al. 2004) and -2 (SYNJ2) (Malecz et al. 2000) dephosphorylate phosphatidylinositol 4-phosphate (PI4P) phosphatidylinositol (PI). The SAC1 domains of SYNJ1 and SYNJ2 demonstrate 4-phosphatase activity.
R-HSA-1675994 (Reactome) At the plasma membrane, synaptojanin-1 aka Synaptic inositol-1,4,5-trisphosphate 5-phosphatase 1 (SYNJ1) (Guo et al. 1999), -2 (SYNJ2) and some myotubularins (MTMs) dephosphorylate phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol (PI). The MTMs involved are: myotubularin (MTM1) (Cao et al. 2007, Tronchere et al. 2004, Schaletzky et al. 2003, Laporte et al. 2002, Kim et al. 2002) and myotubularin-related proteins 1 (MTMR1) (Kim et al. 2002, Tronchere et al. 2004), 3 (MTMR3) (Kim et al. 2002, Zhao et al. 2001, Walker et al. 2001, Lorenzo et al. 2005), 6 (MTMR6) (Schaletzky et al. 2003, Kim et al. 2002, Choudhury et al. 2006), and 14 (MTMR14) (Tosch et al. 2006).
R-HSA-1676005 (Reactome) At the Golgi membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger. The FIG4 phosphatase component dephosphorylates phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 3-phosphate (PI3P) (Sbrissa et al. 2007, Sbrissa et al. 2008).
R-HSA-1676020 (Reactome) At the late endosome membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger. The FIG4 phosphatase component dephosphorylates phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 3-phosphate (PI3P) (Sbrissa et al. 2007, Sbrissa et al. 2008).
R-HSA-1676024 (Reactome) At the late endosome membrane, phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) aka VPS34 binds to phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4). The PIK3C3:PIK3R4 complex and phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) phosphorylate phosphatidylinositol (PI) to phosphatidylinositol 3-phosphate (PI3P).

The following lists the above proteins with their corresponding literature references: PIK3C3:PIK3R4 (Panaretou et al. 1997, Volinia et al. 1995, Cao et al. 2007) and PIK3C2A (Arcaro et al. 2000, Domin et al. 2000).
R-HSA-1676041 (Reactome) The presence of phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) in the early endosome membrane stimulates the vesicle maturation into the late endosome (Cabezas et al. 2006, Ikonomov et al. 2006, Ikonomov et al. 2001).
R-HSA-1676048 (Reactome) At the plasma membrane, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunits form complexes with regulatory subunits. These complexes phosphorylate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) (Stephens et al. 1997). The PI(4,5)P2 3-kinase complexes involved are: PI(4,5)P2 3-kinase catalytic subunit alpha isoform (PIK3CA) bound to PI 3-kinase regulatory subunit alpha/beta/gamma (PIK3R1/2/3); beta (PIK3CB) bound to PIK3R1/2/3; delta (PIK3CD) bound to PIK3R1/2/3; and gamma (PIK3CG) bound to PI 3-kinase regulatory subunit 5 (PIK3R5) or 6 (PIK3R6).

The following lists the above proteins with their corresponding literature references: PIK3CA:PIK3R1, PIK3CA:PIK3R2, PIK3CA:PIK3R3 (Dey et al. 1998, Vanhaesebroeck et al. 1997, Meier et al. 2004); PIK3CB:PIK3R1, PIK3CB:PIK3R2, PIK3CB:PIK3R3 (Meier et al. 2004); PIK3CD:PIK3R1, PIK3CD:PIK3R2, PIK3CD:PIK3R3 (Vanhaesebroeck et al. 1997, Meier et al. 2004); and PIK3CG:PIK3R5, PIK3CG:PIK3R6 (Voigt et al. 2006, Suire et al. 2005, Stoyanov et al. 1995).
R-HSA-1676065 (Reactome) At the late endosome membrane, myotubularin (MTM1), myotubularin-related protein 2 (MTMR2), myotubularin-related protein 4 (MTMR4), and myotubularin-related protein 7 (MTMR7) dephosphorylate phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 5-phosphate (PI5P).

The following lists the above proteins with their corresponding literature references: MTM1 (Cao et al. 2007, Cao et al. 2008, Tsujita et al. 2004, Tronchere et al. 2004), MTMR2 (Cao et al. 2008), MTMR4 (Lorenzo et al. 2006), and MTMR7 (Mochizuki & Majerus 2003, Lorenzo et al. 2006).
R-HSA-1676082 (Reactome) At the plasma membrane, phosphatidylinositol-4-phosphate 5-kinase type-1 alpha (PIP5K1A), beta (PIP5K1B), and gamma (PIP5K1C) phosphorylate phosphatidylinositol 4-phosphate (PI4P) to produce phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2).

The following lists the above proteins with their corresponding literature references: PIP5K1A (Halstead et al. 2006, Zhang et al. 1997), PIP5K1B (Zhang et al. 1997), and PIP5K1C (Di Paolo et al. 2002).

This reaction is of particular interest because its regulation by small GTPases of the RHO and ARF families, not yet annotated here, ties the process of phosphatidylinositol phosphate biosynthesis to regulation of the actin cytoskeleton and vesicular trafficking, and hence to diverse aspects of cell motility and signalling (Oude Weernink et al. 2004, 2007).
R-HSA-1676105 (Reactome) At the early endosome membrane, myotubularin (MTM1), myotubularin-related protein 2 (MTMR2) and myotubularin-related protein 4 (MTMR4) dephosphorylate phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 5-phosphate (PI5P).

The following lists the above proteins with their corresponding literature references: MTM1 (Cao et al. 2007, Cao et al. 2008), MTMR2 (Cao et al. 2008), and MTMR4 (Lorenzo et al. 2006).
R-HSA-1676109 (Reactome) At the plasma membrane, phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) 3-kinase catalytic subunits form complexes with regulatory subunits. These complexes along with phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunits alpha (PIK3C2A), beta (PIK3C2B), and gamma (PIK3C2G) phosphorylate phosphatidylinositol 4-phosphate (PI4P) to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). The PI(4,5)P2 3-kinase complexes involved are: PI(4,5)P2 3-kinase catalytic subunit alpha isoform (PIK3CA) bound to PI 3-kinase regulatory subunit alpha/beta/gamma (PIK3R1/2/3); beta (PIK3CB) bound to PIK3R1/2/3; delta (PIK3CD) bound to PIK3R1/2/3; and gamma (PIK3CG) bound to PI 3-kinase regulatory subunit 5 (PIK3R5) or 6 (PIK3R6).

The following lists the above proteins with their corresponding literature references: PIK3C2A (Arcaro et al. 2000); PIK3C2B (Arcaro et al. 2000, Arcaro et al. 1998); PIK3C2G (Misawa et al. 1998, Ono et al. 1998); PIK3CA:PIK3R1, PIK3CA:PIK3R2, PIK3CA:PIK3R3 (Vanhaesebroeck et al. 1997); PIK3CB:PIK3R1, PIK3CB:PIK3R2, PIK3CB:PIK3R3 (Meier et al. 2004, Guo et al. 1997); PIK3CD:PIK3R1, PIK3CD:PIK3R2, PIK3CD:PIK3R3 (Vanhaesebroeck et al. 1997); and PIK3CG:PIK3R5, PIK3CG:PIK3R6 (Suire et al. 2005, Stoyanov et al. 1995).
R-HSA-1676114 (Reactome) At the Golgi membrane, phosphatidylinositide phosphatase SAC1 (SACM1L) dephosphorylates phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol (PI) but not as efficiently as phosphatidylinositol 4-phosphate (PI4P) dephosphorylation. No significant activity of this enzyme towards phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) was detected (Rohde et al. 2003).
R-HSA-1676124 (Reactome) At the endoplasmic reticulum (ER) membrane, transmembrane protein phosphatidylinositide phosphatase SAC1 (SACM1L) efficiently dephosphorylates phosphatidylinositol 4-phosphate (PI4P), and to a lesser extent phosphatidylinositol 3-phosphate (PI3P), to phosphatidylinositol (PI). No significant activity of this enzyme towards phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) was detected (Rohde et al. 2003).
R-HSA-1676133 (Reactome) At the Golgi membrane, phosphatidylinositide phosphatase SAC1 (SACM1L) efficiently dephosphorylates phosphatidylinositol 4-phosphate (PI4P), and to a lesser extent phosphatidylinositol 3-phosphate (PI3P), to phosphatidylinositol (PI). No significant activity of this enzyme towards phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) was detected (Rohde et al. 2003).
R-HSA-1676134 (Reactome) At the plasma membrane, phosphatidylinositol-4-phosphate 5-kinase type-1 alpha (PIP5K1A) and beta (PIP5K1B) phosphorylate phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (Tolias et al. 1998).
R-HSA-1676141 (Reactome) At the early endosome membrane, myotubularin (MTM1), myotubularin-related protein 2 (MTMR2), and myotubularin-related protein 4 (MTMR4) dephosphorylate phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol (PI).

The following lists the above proteins with their corresponding literature references: MTM1 (Cao et al. 2007, Cao et al. 2008, Kim et al. 2002), MTMR2 (Cao et al. 2008, Kim et al. 2002), and MTMR4 (Lorenzo et al. 2006, Zhao et al. 2001).
R-HSA-1676145 (Reactome) At the plasma membrane, phosphatidylinositol-5-phosphate 4-kinase type-2 alpha (PIP4K2A) and beta (PIP4K2B) homodimers and heterodimers (Clarke et al. 2010), along with phosphatidylinositol-4-phosphate 5-kinase type-1 alpha (PIP5K1A), beta (PIP5K1B), and gamma (PIP5K1C) phosphorylate phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2).

The following lists the above proteins with their corresponding literature references: PIP4K2A (Zhang et al. 1997, Rameh et al. 1997, Clarke et al. 2008), PIP4K2B (Zhang et al. 1997, Rameh et al. 1997), PIP5K1A (Zhang et al. 1997, Tolias et al. 1998), PIP5K1B (Zhang et al. 1997, Tolias et al. 1998), and PIP5K1C (Wenk et al. 2001, Di Paolo et al. 2002).
R-HSA-1676149 (Reactome) At the plasma membrane, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase aka phosphatase and tensin homolog (PTEN) dephosphorylates phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) to phosphatidylinositol 4-phosphate (PI4P) (Myers et al. 1998, Das et al. 2003).
Early studies indicated that magnesium ion, Mg2+, was needed for the catalytic activity of PTEN isolated from bovine thymus (Kabuyama et al. 1996). Subsequent studies have shown that PTEN was catalytically active in buffers free of magnesium and magnesium was not detected as part of the PTEN crystal (Lee et al. 1999).
R-HSA-1676152 (Reactome) At the Golgi membrane, ADP-ribosylation factor 1 and 3 (ARF1 and ARF3) complexed to GTP bind to phosphatidylinositol 4-kinase beta (PI4KB) and activate it (Haynes et al. 2007, Wong et al. 1997, Godi et al. 1999).
R-HSA-1676161 (Reactome) Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) translocates from the late endosome membrane to the Golgi membrane (Rutherford et al. 2006).
R-HSA-1676162 (Reactome) At the early endosome membrane, type I (INPP4A) (Norris et al. 1995, Ivetac et al. 2005) and type II inositol-3,4-bisphosphate 4-phosphatase (INPP4B) (Norris et al. 1997) colocalise with early and recycling endosomes through their C2 domains which bind to the phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) present in these membranes. It is here that phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) is dephosphorylated by INPP4A/B to phosphatidylinositol 3-phosphate (PI3P).
R-HSA-1676164 (Reactome) At the plasma membrane, type I and type II inositol-3,4-bisphosphate 4-phosphatase (INPP4A) (Norris et al. 1995, Ivetac et al. 2005) and (INPP4B) (Norris et al. 1997) dephosphorylate phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) to phosphatidylinositol 3-phosphate (PI3P).
R-HSA-1676168 (Reactome) At the early endosome membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger (Sbrissa et al. 2002, Cao et al. 2007). The PIKFYVE kinase component phosphorylates phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol 3,5-bisphosphate PI(3,5)P2 (Sbrissa et al. 1999). The PAS complex is present in the cytosol and is recruited to the membrane (Sbrissa et al. 2007).
R-HSA-1676174 (Reactome) At the early endosome membrane, the PAS complex, consisting of FYVE finger-containing phosphoinositide kinase (PIKFYVE), yeast VAC14 homologue (VAC14), and polyphosphoinositide phosphatase aka SAC3 (FIG4), binds to the membrane via PIKFYVE's FYVE finger. The FIG4 phosphatase component dephosphorylates phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 3-phosphate (PI3P) (Sbrissa et al. 2007, Sbrissa et al. 2008).
R-HSA-1676177 (Reactome) At the plasma membrane, Synaptojanin-1 (SYNJ1) and -2 (SYNJ2), inositol polyphosphate 5-phosphatase K (INPP5K) aka SKIP, phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (INPP5J) aka PIPP dephosphorylate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to form phosphatidylinositol 4-phosphate (PI4P). SYNJ1/2 both have an N-terminal Sac1-like domain, a central 5-phosphatase domain and a C-terminal proline-rich segment, with this latter part being the most divergent part of the protein sequence.

The following lists the above proteins with their corresponding literature references: SYNJ1 (Johenning et al. 2004, Haffner et al. 1997, Guo et al. 1999, Mani et al. 2007), SYNJ2 (Malecz et al. 2000), INPP5K (Injuin et al. 2000, Gurung et al. 2003), and INPP5J (Gurung et al. 2003, Mochizuki & Takenawa 1999).
R-HSA-1676185 (Reactome) At the Golgi membrane, phosphatidylinositol 4-kinase alpha (PI4KA) (Gehrmann et al. 1999, Godi et al. 1999), or phosphatidylinositol 4-kinase type 2-alpha/beta (PI4K2A/B) (Balla et al. 2002, Minogue et al. 2001, Wei et al. 2002) phosphorylate phosphatidylinositol (PI) to produce phosphatidylinositol 4-phosphate (PI4P).
R-HSA-1676203 (Reactome) At the plasma membrane, synaptojanin-1 aka Synaptic inositol-1,4,5-trisphosphate 5-phosphatase 1 (SYNJ1) (Guo et al. 1999), -2 (SYNJ2) and some myotubularins (MTMs) dephosphorylate phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) to phosphatidylinositol 5-phosphate (PI5P). The MTMs involved are: myotubularin (MTM1) (Cao et al. 2007, Tronchere et al. 2004, Schaletzky et al. 2003, Laporte et al. 2002) and myotubularin-related proteins 1 (MTMR1) (Tronchere et al. 2004), 3 (MTMR3) (Walker et al. 2001, Lorenzo et al. 2005), 6 (MTMR6) (Schaletzky et al. 2003, Choudhury et al. 2006), and 14 (MTMR14) (Tosch et al. 2006).
R-HSA-1676204 (Reactome) At the Golgi membrane, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase (TPTE2) aka TPIP dephosphorylates phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) to produce phosphatidylinositol 4-phosphate (PI4P) (Tapparel et al. 2000, Walker et al. 2001). The transmembrane phosphatase TPTE2 gamma isoform colocalises in the Golgi and the endoplasmic reticulum (Tapparel et al. 2000).
R-HSA-1676206 (Reactome) At the early endosome membrane, phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) (Kraq et al. 2010, Arcaro et al. 2000) phosphorylates phosphatidylinositol 4-phosphate (PI4P) to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2).
R-HSA-199456 (Reactome) At the plasma membrane, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase aka phosphatase and tensin homolog (PTEN) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (Maehama & Dixon 1998, Myers et al. 1998, Das et al. 2003). The PI3K network is negatively regulated by phospholipid phosphatases that dephosphorylate PIP3, thus hampering AKT activation (Myers et al. 1998). The tumour suppressor PTEN is the primary phospholipid phosphatase.
Early studies indicated that magnesium ion, Mg2+, was needed for the catalytic activity of PTEN isolated from bovine thymus (Kabuyama et al. 1996). Subsequent studies have shown that PTEN was catalytically active in buffers free of magnesium and magnesium was not detected as part of the PTEN crystal (Lee et al. 1999).
R-HSA-6809238 (Reactome) MTMR7 binds to MTMR9, an enzymatically inactive myotubularin family member, which results in increased enzymatic activity of MTMR7. Almost all MTMR7 in the cell is present in the complex with MTMR9 (Mochizuki and Majerus 2003).
R-HSA-6809254 (Reactome) MTMR8 binds to MTMR9, an enzymatically inactive myotubularin family member, which results in increased stability and increased catalytic activity of MTMR8 (Zou et al. 2012).
R-HSA-6809309 (Reactome) MTMR6 binds to MTMR9, an enzymatically inactive myotubularin family member, which leads to increased catalytic activity of MTMR6 (Zou et al. 2009).
R-HSA-6809320 (Reactome) Formation of a complex with MTMR9 results in a 30-fold increase of phosphatidylinositol-(3,5)-bisphosphate 3-phosphatase catalytic activity of MTMR6 and a modest increase in the catalytic activity of MTMR8 (Zou et al. 2009, Zou et al. 2012).
R-HSA-6809325 (Reactome) Formation of a complex with MTMR9 results in a 4-fold increase of the phosphatidylinositol-3-phosphatase catalytic activity of MTMR8 and a modest increase of the catalytic activity of MTMR6 (Zou et al. 2012).
R-HSA-6809680 (Reactome) MTM1 forms a complex with MTMR12 (3 PAP), an enzymatically inactive myotubularin family member. MTMR12 promotes MTM1 recruitment to cytosolic vesicular structures, presumably early or late endosomes. Complex formation stabilizes both MTM1 and MTMR12 proteins (Caldwell et al. 1991, Nandurkar et al. 2003, Gupta et al. 2013).
R-HSA-6809707 (Reactome) MTMR2 forms a complex with MTMR12, an enzymatically inactive myotubularin family member. The consequences of this interaction on enzymatic activity and localization of MTMR2 have not been examined (Nandurkar et al. 2003).
R-HSA-6809720 (Reactome) Binding of MTMR12 to MTM1 enhances phosphatidylinositol-3-phosphatase activity of MTM1 at cytosolic vesicular structures, presumably early or late endosomes (Caldwell et al. 1991, Nandurkar et al. 2003, Gupta et al. 2013).
R-HSA-6809764 (Reactome) MTMR2 forms a heterodimer with SBF1 (MTMR5), an enzymatically inactive myotubularin family member. The interaction of MTMR2 and SBF1 involves coiled-coil domains of both proteins. SBF1 promotes perinuclear localization of MTMR2 (Kim et al. 2003), presumably to the endoplasmic reticulum(ER) membrane, as both proteins can localize to the ER membrane (Berger et al. 2003, Li et al. 2014).
R-HSA-6809777 (Reactome) Binding to SBF1 (MTMR5) increases phosphatidylinositol-3-phosphatase catalytic activity of MTMR2 (Kim et al. 2003). SBF1 promotes perinuclear localization of MTMR2 (Kim et al. 2003), presumably to the endoplasmic reticulum (ER) membrane, as both proteins can localize to the ER membrane (Berger et al. 2003, Li et al. 2014).
R-HSA-6809778 (Reactome) Formation of the complex with SBF1 (MTMR5) increases phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity of MTMR2 (Kim et al. 2003). SBF1 promotes perinuclear localization of MTMR2 (Kim et al. 2003), presumably to the endoplasmic reticulum(ER) membrane, as both proteins can localize to the ER membrane (Berger et al. 2003, Li et al. 2014).
R-HSA-6809785 (Reactome) MTMR2 forms a homodimer (Berger et al. 2006).
R-HSA-6809793 (Reactome) MTMR2 dimer forms a complex with myotubularin protein SBF2 (MTMR13, an enzymatically inactive myotubularin family member) dimer. Binding to SBF2 sequesters MTMR2 from endosomal membranes to the cytosol (Berger et al. 2006).
R-HSA-6809944 (Reactome) Formation of a complex with SBF2 (MTMR13) dramatically increases phosphatidylinositol-(3,5)-bisphosphate 3-phosphatase catalytic activity of MTMR2. Since SBF2 sequesters MTRM2 from endosome membranes, the MTMR2 presumably acts on the plasma membrane-associated substrate (Berger et al. 2006).
R-HSA-6809975 (Reactome) Formation of the complex with SBF2 (MTMR13) dramatically increases phosphatidylinositol-3-phosphatase catalytic activity of MTMR2. Since SBF2 sequesters MTRM2 from endosome membranes, the MTMR2 presumably acts on the plasma membrane-associated substrate (Berger et al. 2006).
R-HSA-6810030 (Reactome) Based on a high throughput study of human interactome in HeLa cells, MTMR2 forms a complex with MTMR10, an enzymatically inactive myotubularin family member. The function of this complex has not been examined (Hein et al. 2015).
R-HSA-6810392 (Reactome) Under conditions of cellular stress, TMEM55B (type I phosphatidylinositol 4,5-bisphosphate 4-phosphatase) translocates to the nucleus through an unknown mechanism (Zou et al. 2007).
R-HSA-6810410 (Reactome) Translocation of TMEM55B (type I phosphatidylinositol 4,5-bisphosphate 4-phosphatase) to the nucleus under conditions of cellular stress leads to dephosphorylation of nuclear PI(4,5)P2 to PI5P, thus increasing the concentration of PI5P in the nucleus (Zou et al. 2007). PIP2 and its derivatives are not associated with nuclear envelope structures (Bornenkov et al. 1998) but localize to poorly defined subnuclear compartments called nuclear specks (reviewed by Barlow et al. 2010).
R-HSA-6811522 (Reactome) In the nucleus, phosphatidylinositol 5-phosphate (PI5P) is phosphorylated to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) mainly by phosphatidylinositol-5-phosphate 4-kinase type-2 beta (PIP4K2B). In the nucleus, PIP4K2B predominantly functions as a homodimer or a heterodimer with PIP4K2A. A low level of PIP4K2A homodimers can also be found in the nucleus. Nuclear localization of PIP4K2C has not been examined but is assumed to be possible, at least through formation of heterodimers with PIP4K2B (Ciruela et al. 2000, Jones et al. 2006, Bultsma et al. 2010). Under conditions of cellular stress, nuclear PIP4K2B can be phosphorylated by p38 MAP kinases, resulting in PIP4K2B inactivation. The putative p38 target site, serine residue S326 of PIP4K2B, is conserved in PIP4K2A, but the role and mechanism of p38-mediated regulation of PIP4K2 isoforms has not been studied in detail (Jones et al. 2006).
R-HSA-6813740 (Reactome) GDE1 (glycerophosphodiester phosphodiesterase 1) catalyzes the hydrolysis of GroPIns (1-(sn-glycero-3-O-phosphonato)-1D-myo-inositol; glycerophosphoinositol) to G3P (glycerol-3-phosphate) and Ins (inositol). Experimental studies of the homologous rat enzyme have shown it to be associated with cellular membranes, to have a strong preference for glycerophosphoinositol over glycerophosphocholine as a substrate, and to be stimulated by G protein agonists, suggesting a possible role for GDE1 in signaling by G protein-coupled receptors (Zheng et al. 2000, 2003). Modeling studies with the human protein have been interpreted to suggest localization specifically to the plasma membrane (Bachmann et al. 2006).
R-HSA-6814132 (Reactome) GDPD5 (Glycerophosphodiester phosphodiesterase domain-containing protein 5; GDE2) catalyzes the hydrolysis of GPCho (glycero-3-phosphocholine) to G3P (glycerol-3-phosphate) and Cho (choline). The localization and activity of human GDPD5 are inferred from those of its better-characterized mouse homolog (Gallazzini et al. 2008).
R-HSA-6814254 (Reactome) PNPLA6 (Patatin-like phospholipase domain-containing protein 6, also known as NTE - Neuropathy target esterase) associated with the endoplasmic reticulum membrane catalyzes the hydrolysis of LysoPtcCho (lysophosphatidylcholine) to GPCho (glycerophosphocholine) and LCFA (long chain fatty acid). The subcellular location of the enzyme and its specificity have been established through studies of recombinant human enzyme (Li et al. 2003; Zaccheo et al. 2004). Additional studies in a mouse system indicate that enzyme abundance and activity are regulated by osmotic stress in the kidney (Gallazzini et al. 2006).
R-HSA-6814766 (Reactome) GDPD1 (Glycerophosphodiester phosphodiesterase domain-containing protein 1, also known as GDE4 - Glycerophosphodiester phosphodiesterase 4) associated with the endoplasmic reticulum membrane catalyzes the hydrolysis of LysoPtcCho (lysophosphatidylcholine) to GPCho (glycerophosphocholine) and LCFA (long chain fatty acid). The human protein has been characterized only to a limited extent; its enzymatic activity and predominant intracellular localization are inferred from in vitro studies of the recombinant homologous mouse protein (Oshima et al. 2015).
R-HSA-6814778 (Reactome) GDPD3 (Glycerophosphodiester phosphodiesterase domain-containing protein 3, also known as GDE7 - Glycerophosphodiester phosphodiesterase 7) associated with the endoplasmic reticulum membrane catalyzes the hydrolysis of LysoPtcCho (lysophosphatidylcholine) to GPCho (glycerophosphocholine) and LCFA (long chain fatty acid). The human protein has been characterized only to a limited extent; its enzymatic activity and predominant intracellular localization are inferred from in vitro studies of the recombinant homologous mouse protein (Oshima et al. 2015).
R-HSA-6814797 (Reactome) ENPP6 (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) associated with the plasma membrane catalyzes the hydrolysis of lysophosphatidylcholine to ChoP (phosphocholine) and MAG (monoacylglycerol), as demonstrated by characterization of the recombinant human protein expressed in cells in culture (Sakagami et al. 2005).
R-HSA-8847912 (Reactome) PNPLA7 (Patatin-like phospholipase domain-containing protein 7, also known as NRE - NTE-related esterase) associated with the endoplasmic reticulum membrane catalyzes the hydrolysis of LysoPtcCho (lysophosphatidylcholine) to GPCho (glycerophosphocholine) and LCFA (long chain fatty acid). The human enzyme is expressed most abundantly in prostate, pancreas, and adipose tissues (Wilson et al. 2006). Its location and enzymatic activity have been inferrred from the properties of its mouse homologue (Kienesberger et al. 2008).
R-HSA-8849969 (Reactome) Characterization of human INPP5F (SAC2) identified that it is a 4-phosphatase with highest activity against PI(4,5)P2, PI(3,4)P2, and PI(3,4,5)P3, generating PI(5)P, PI(3)P and PI(3,5)P2 respectively (Nakatsu et al. 2015, Hsu et al. 2015). Inpp5f -/- mice have elevated level of PIP3 and exhibit accentuated cardiac hypertrophy as measured by heart size, myocyte size and gene expression (Zhu et al. 2009).
R-HSA-8870332 (Reactome) Insulin sensitivity is critically dependent on the activity of PI3K (phosphoinositide 3-kinase) and generation of the phosphatidylinositol 3,4, 5-triphosphate (PIP3,PtdIns(3,4,5)P(3)) second messenger. Increasing evidence suggests that one of the immediate breakdown products of PIP3, phosphatidylinositol 3,4-diphosphate (PIP2, PtdIns(3,4)P(2)), might also function as a signalling molecule by controlling a negative-feedback loop that down-regulates the insulin and PI3K network. The pleckstrin homology domain-containing family A members 1 and 2 (PLEKHA1 and PLEKHA2, aka TAPP1 and TAPP2 respectively) can both specifically bind PIP2. PLEKHA1 and 2 are constituitively bound to tyrosine-protein phosphatase non-receptor type 13 (PTPN13, aka PTPL1) via its first PDZ domain and this interaction keeps PLEKHA1 and 2 localised to the cytosol (Kimber et al. 2003). With increasing PIP2 levels, produced by PI3K activity on PIP3, PTPN13-bound PLEKHA1 and 2 translocate to the plasma membrane where they bind PIP2 (Marshall et al. 2002, Wullschleger et al. 2011).
R-HSA-8870489 (Reactome) The second messenger phosphatidylinositol 3,4,5-trisphosphate

(PIP3, PtdIns(3,4,5)P) is generated by the action of phosphoinositide 3-kinase (PI3K) in response to growth factors and insulin and regulates a range of cellular processes. Proteins containing the plekstrin homology (PH) domain can interact specifically with PIP3 or its immediate breakdown product, phosphatidylinositol 3,4-diphosphate (PIP2, PtdIns(3,4)P). Proteins with a PH domain have also been found to bind to PIs other than PIP3 or PIP2. Pleckstrin homology domain-containing family A member 4 (PLEKHA4 aka PEPP1) is able to specifically bind phosphatidylinositol 3-phosphate (PI3P) but not other phosphoinositides (Dowler et al. 2000). Two related isoforms of

PLEKHA4, PLEKHA5 and 6 (PEPP2 and PEPP3), possess a very similar PH domain sequence, indicating that they may also interact with PI3P (Dowler et al. 2000, Yamada et al. 2012). These proteins may function as adaptor molecules since they possess no obvious catalytic moieties.
R-HSA-8870499 (Reactome) Proteins with the plekstrin homology (PH) domain are able to bind specific phosphoinositides. Pleckstrin homology domain-containing family A members 3 and 8 (PLEKHA3 and PLEKHA8 aka FAPP1 and FAPP2) specifically bind phosphoinositide 4-phosphate (PI4P, PtdIns(4)P), a key intermediate in the synthesis of phosphoinositide 4,5-diphosphate (PIP2). PLEKHA3 and 8 are localised to the trans-Golgi network (TGN) where they interact with PI4P and the small GTPase ADP-ribosylation factor (ARF1) through their PH domains and mediate the transport of lipid cargo from the Golgi to the plasma membrane (Godi et al. 1999, Godi et al. 2004).
R-HSA-8871366 (Reactome) RUN and FYVE domain-containing protein 1 (RUFY1, aka RABIP4, ZFYVE12), together with Ras-related proteins RAB4A, 5 and 14, could play an important role in GLUT4 trafficking in adipocytes and skeletal muscle (Kitagishi & Matsuda 2013, Larance et al. 2005, Mari et al. 2006, Fouraux et al. 2004).
R-HSA-8871370 (Reactome) RUN and FYVE domain-containing protein 1 (RUFY1, aka RABIP4, ZFYVE12) associates with phosphatidylinositol 3-phosphate in membranes of early endosomes and may participate in early endosomal membrane trafficking of the glucose transporter GLUT4. RUFY1 is localised to the cytoplasm and early endosomal membrane, the latter being the predominant localisation after RUFY1 is phosphorylated. Cytoplasmic tyrosine-protein kinase BMX (BMX, aka ETK) is a a downstream tyrosine kinase of PI3-kinase which, through its SH2 and SH3 domains, binds to and phosphorylates RUFY1 at Tyr-281 and Tyr 292. These phosphorylations are essential for endosomal localisation (Yang et al. 2002).
R-HSA-8871373 (Reactome) RUN and FYVE domain-containing protein 1 (RUFY1, aka RABIP4, ZFYVE12) associates with phosphatidylinositol 3-phosphate in membranes of early endosomes and may participate in early endosomal membrane trafficking of the glucose transporter GLUT4. RUFY1 is broadly expressed, with highest levels in lung, testis, kidney and brain. RUFY1 is localised to the cytoplasm and early endosomal membrane, the latter being the predominant localisation after RUFY1 is phosphorylated. Cytoplasmic tyrosine-protein kinase BMX (BMX, aka ETK) is a a downstream tyrosine kinase of PI3-kinase which, through its SH2 and SH3 domains, binds to and phosphorylates RUFY1 at Tyr-281 and Tyr 292. These phosphorylations are essential for endosomal localisation (Yang et al. 2002).
R-HSA-8871376 (Reactome) RUN and FYVE domain-containing protein 1 (RUFY1, aka RABIP4, ZFYVE12) associates with phosphatidylinositol 3-phosphate in membranes of early endosomes and may participate in early endosomal membrane trafficking. RUFY1 is localised to the cytoplasm and early endosomal membrane, the latter being the predominant localisation after RUFY1 is phosphorylated. Cytoplasmic tyrosine-protein kinase BMX (BMX, aka ETK) is a a downstream tyrosine kinase of PI3-kinase which, through its SH2 and SH3 domains, binds to and phosphorylates RUFY1 at Tyr-281 and Tyr 292. These phosphorylations are essential for endosomal localisation (Yang et al. 2002).
R-HSA-8874470 (Reactome) The tumor necrosis factor alpha-induced protein 8 family are all thought to be related to carcinogenesis (Lou & Liu 2011). TNFAIP8 and TNFAIP8L1 (aka TIPE1) may play roles in oncogenesis and TNFAIP8L2 (aka TIPE2) is an essential negative regulator of both innate and adaptive immunity and may play an important role in the development of inflammatory diseases. TNFAIP8L3 (aka TIPE3) is an important regulator of tumorigenesis through its activation of phospholipid signaling (Fayngerts et al. 2014). TNFAIP8 proteins are cytosolic proteins that contain a large hydrophobic cavity that is occupied by a phospholipid-like molecule. Although TNFAIP8 proteins can transport many phospholipids, they are thought to preferentially transport phosphoinositol-4,5-bisphosphate (PI(4,5)P2) and phosphoinositol-3,4,5-trisphosphate (PI(3,4,5)P3) from cytoplasmic vesicle membranes to the plasma membrane (Moniz & Vanhaesebroeck 2014, Cui et al. 2015). TNFAIP8L3 is highly expressed in most human carcinoma cell lines and more than half of human cancers have aberrantly upregulated phosphoinositide signals. How phospholipid signals are controlled during tumorigenesis is not fully understood (Fayngerts et al. 2014).
RAB14:GTPR-HSA-8871366 (Reactome)
RAB4A:GTPR-HSA-8871366 (Reactome)
RAB5A:GTPR-HSA-8871366 (Reactome)
RUFY1R-HSA-8871373 (Reactome)
SACM1Lmim-catalysisR-HSA-1676114 (Reactome)
SACM1Lmim-catalysisR-HSA-1676124 (Reactome)
SACM1Lmim-catalysisR-HSA-1676133 (Reactome)
SBF1R-HSA-6809764 (Reactome)
SBF2 homodimerR-HSA-6809793 (Reactome)
SYNJ/INPP5(1)mim-catalysisR-HSA-1676177 (Reactome)
SYNJs,OCRLmim-catalysisR-HSA-1675836 (Reactome)
SYNJs,OCRLmim-catalysisR-HSA-1675988 (Reactome)
TMEM55BArrowR-HSA-6810392 (Reactome)
TMEM55BR-HSA-6810392 (Reactome)
TMEM55Bmim-catalysisR-HSA-6810410 (Reactome)
TNFAIP8 proteinsmim-catalysisR-HSA-8874470 (Reactome)
TPTE2-like proteinsmim-catalysisR-HSA-1676204 (Reactome)
lysophosphatidylcholineR-HSA-6814797 (Reactome)
p-Y281,292-RUFY1:PI3PArrowR-HSA-8871376 (Reactome)
p-Y281,292-RUFY1:p-Y281,292-RUFY1:RAB4A:GTP:RAB5:GTP:RAB14:GTPArrowR-HSA-8871366 (Reactome)
p-Y281,292-RUFY1ArrowR-HSA-8871370 (Reactome)
p-Y281,292-RUFY1ArrowR-HSA-8871373 (Reactome)
p-Y281,292-RUFY1R-HSA-8871366 (Reactome)
p-Y281,292-RUFY1R-HSA-8871370 (Reactome)
p-Y281,292-RUFY1R-HSA-8871376 (Reactome)
Personal tools